Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-127-3p PPARG -0.63 0.04008 0.8 0.14249 miRanda -0.27 0.00145 NA
2 hsa-miR-130a-3p PPARG 2.02 0 0.8 0.14249 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.21 0.01438 NA
3 hsa-miR-142-3p PPARG 2.75 0 0.8 0.14249 miRanda -0.29 1.0E-5 NA
4 hsa-miR-27a-3p PPARG 1.67 0 0.8 0.14249 MirTarget; miRNATAP -0.61 0 NA
5 hsa-miR-338-5p PPARG -0.58 0.04722 0.8 0.14249 MirTarget; PITA; miRNATAP -0.42 0 NA
6 hsa-miR-34c-5p PPARG 2.07 0 0.8 0.14249 miRanda -0.32 1.0E-5 NA
7 hsa-miR-455-5p PPARG 2.26 0 0.8 0.14249 miRanda -0.29 0.00047 NA
8 hsa-miR-511-5p PPARG 1.04 0.00234 0.8 0.14249 MirTarget -0.34 1.0E-5 NA
NumGOOverlapSizeP ValueAdj. P Value
1 REGULATION OF CELL PROLIFERATION 175 1496 5.021e-69 2.336e-65
2 POSITIVE REGULATION OF RESPONSE TO STIMULUS 191 1929 4.896e-64 1.139e-60
3 REGULATION OF CELL DEATH 165 1472 7.327e-62 1.136e-58
4 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 181 1848 2.025e-59 2.356e-56
5 IMMUNE SYSTEM PROCESS 185 1984 1.427e-57 1.328e-54
6 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 155 1395 3.64e-57 2.823e-54
7 RESPONSE TO OXYGEN CONTAINING COMPOUND 151 1381 1.311e-54 8.712e-52
8 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 170 1805 7.64e-53 4.444e-50
9 POSITIVE REGULATION OF GENE EXPRESSION 166 1733 1.855e-52 9.589e-50
10 RESPONSE TO ENDOGENOUS STIMULUS 151 1450 7.852e-52 3.654e-49
11 NEGATIVE REGULATION OF CELL DEATH 118 872 1.539e-51 6.509e-49
12 REGULATION OF CELL DIFFERENTIATION 150 1492 1.739e-49 6.741e-47
13 RESPONSE TO EXTERNAL STIMULUS 165 1821 9.16e-49 3.279e-46
14 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 157 1672 3.996e-48 1.328e-45
15 LOCOMOTION 128 1114 5.144e-48 1.596e-45
16 RESPONSE TO LIPID 113 888 1.684e-46 4.896e-44
17 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 125 1142 1.633e-44 4.469e-42
18 POSITIVE REGULATION OF CELL COMMUNICATION 144 1532 9.025e-44 2.333e-41
19 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 104 799 1.497e-43 3.666e-41
20 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 130 1275 5.411e-43 1.259e-40
21 RESPONSE TO ORGANIC CYCLIC COMPOUND 110 917 1.088e-42 2.41e-40
22 REGULATION OF RESPONSE TO STRESS 139 1468 1.791e-42 3.661e-40
23 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 154 1784 1.81e-42 3.661e-40
24 REGULATION OF IMMUNE SYSTEM PROCESS 135 1403 6.309e-42 1.223e-39
25 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 139 1492 1.159e-41 2.156e-39
26 POSITIVE REGULATION OF CELL PROLIFERATION 102 814 3.6e-41 6.443e-39
27 CELL MOTILITY 103 835 5.796e-41 9.348e-39
28 LOCALIZATION OF CELL 103 835 5.796e-41 9.348e-39
29 REGULATION OF PHOSPHORUS METABOLIC PROCESS 144 1618 5.826e-41 9.348e-39
30 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 105 876 1.242e-40 1.927e-38
31 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 145 1656 1.928e-40 2.894e-38
32 TISSUE DEVELOPMENT 138 1518 3.963e-40 5.762e-38
33 REGULATION OF PROTEIN MODIFICATION PROCESS 147 1710 4.133e-40 5.827e-38
34 REGULATION OF CELLULAR COMPONENT MOVEMENT 97 771 3.105e-39 4.249e-37
35 POSITIVE REGULATION OF LOCOMOTION 73 420 6.842e-39 9.095e-37
36 POSITIVE REGULATION OF MOLECULAR FUNCTION 146 1791 3.985e-37 5.15e-35
37 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 109 1036 6.608e-37 8.092e-35
38 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 109 1036 6.608e-37 8.092e-35
39 POSITIVE REGULATION OF CELL DIFFERENTIATION 97 823 8.329e-37 9.937e-35
40 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 107 1004 1.049e-36 1.221e-34
41 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 105 983 4.45e-36 5.05e-34
42 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 124 1360 7.14e-36 7.91e-34
43 IMMUNE SYSTEM DEVELOPMENT 81 582 7.693e-36 8.325e-34
44 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 112 1135 2.365e-35 2.501e-33
45 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 105 1008 4.158e-35 4.299e-33
46 IMMUNE RESPONSE 109 1100 1.596e-34 1.615e-32
47 RESPONSE TO ABIOTIC STIMULUS 105 1024 1.672e-34 1.656e-32
48 REGULATION OF CELL ADHESION 82 629 3.506e-34 3.399e-32
49 DEFENSE RESPONSE 115 1231 4.261e-34 4.046e-32
50 RESPONSE TO HORMONE 97 893 7.778e-34 7.097e-32
51 RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 60 321 7.644e-34 7.097e-32
52 NEGATIVE REGULATION OF CELL PROLIFERATION 82 643 1.758e-33 1.573e-31
53 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 95 867 2.003e-33 1.758e-31
54 CELL ACTIVATION 77 568 2.935e-33 2.529e-31
55 INFLAMMATORY RESPONSE 69 454 5.987e-33 5.065e-31
56 RESPONSE TO WOUNDING 76 563 1.065e-32 8.848e-31
57 RESPONSE TO CYTOKINE 85 714 1.761e-32 1.437e-30
58 NEGATIVE REGULATION OF CELL COMMUNICATION 110 1192 4.61e-32 3.698e-30
59 CARDIOVASCULAR SYSTEM DEVELOPMENT 88 788 1.57e-31 1.218e-29
60 CIRCULATORY SYSTEM DEVELOPMENT 88 788 1.57e-31 1.218e-29
61 RESPONSE TO BIOTIC STIMULUS 93 886 3.117e-31 2.378e-29
62 CELL DEATH 99 1001 3.613e-31 2.711e-29
63 NEGATIVE REGULATION OF GENE EXPRESSION 122 1493 1.219e-30 9.007e-29
64 POSITIVE REGULATION OF CELL DEATH 76 605 1.413e-30 1.028e-28
65 WOUND HEALING 67 470 2.79e-30 1.997e-28
66 REGULATION OF CYTOKINE PRODUCTION 73 563 2.913e-30 2.054e-28
67 RESPONSE TO NITROGEN COMPOUND 89 859 1.93e-29 1.34e-27
68 ORGAN MORPHOGENESIS 88 841 2.021e-29 1.383e-27
69 POSITIVE REGULATION OF CATALYTIC ACTIVITY 121 1518 2.303e-29 1.553e-27
70 LEUKOCYTE MIGRATION 50 259 5.339e-29 3.549e-27
71 RESPONSE TO BACTERIUM 69 528 8.02e-29 5.256e-27
72 REGULATION OF TRANSPORT 132 1804 1.617e-28 1.045e-26
73 CELLULAR RESPONSE TO LIPID 64 457 1.721e-28 1.097e-26
74 LEUKOCYTE ACTIVATION 61 414 2.08e-28 1.308e-26
75 LEUKOCYTE DIFFERENTIATION 52 292 2.383e-28 1.478e-26
76 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 84 801 3.903e-28 2.389e-26
77 REGULATION OF CELL DEVELOPMENT 85 836 1.605e-27 9.696e-26
78 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 94 1021 3.585e-27 2.138e-25
79 EPITHELIUM DEVELOPMENT 90 945 4.609e-27 2.715e-25
80 VASCULATURE DEVELOPMENT 63 469 5.062e-27 2.944e-25
81 LYMPHOCYTE ACTIVATION 54 342 9.993e-27 5.74e-25
82 REGULATION OF MAPK CASCADE 74 660 1.345e-26 7.634e-25
83 EXTRACELLULAR STRUCTURE ORGANIZATION 51 304 1.495e-26 8.378e-25
84 RESPONSE TO STEROID HORMONE 64 497 2.143e-26 1.187e-24
85 INTRACELLULAR SIGNAL TRANSDUCTION 118 1572 2.913e-26 1.595e-24
86 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 87 926 9.843e-26 5.325e-24
87 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 98 1152 1.081e-25 5.783e-24
88 REGULATION OF KINASE ACTIVITY 79 776 1.321e-25 6.983e-24
89 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 77 740 1.448e-25 7.572e-24
90 BIOLOGICAL ADHESION 92 1032 1.481e-25 7.659e-24
91 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 114 1517 2.296e-25 1.174e-23
92 SINGLE ORGANISM CELL ADHESION 60 459 3.984e-25 2.015e-23
93 REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 42 213 6.888e-25 3.446e-23
94 TISSUE MORPHOGENESIS 64 533 1.092e-24 5.404e-23
95 REGULATION OF PEPTIDASE ACTIVITY 55 392 1.316e-24 6.444e-23
96 CELLULAR RESPONSE TO CYTOKINE STIMULUS 68 606 1.752e-24 8.491e-23
97 CELLULAR RESPONSE TO BIOTIC STIMULUS 37 163 2.491e-24 1.195e-22
98 POSITIVE REGULATION OF TRANSPORT 85 936 3.932e-24 1.867e-22
99 REGULATION OF HYDROLASE ACTIVITY 103 1327 6.681e-24 3.14e-22
100 REGULATION OF TRANSFERASE ACTIVITY 85 946 8.053e-24 3.747e-22
101 RESPONSE TO ALCOHOL 52 362 8.62e-24 3.971e-22
102 REGULATION OF CELL CELL ADHESION 53 380 1.289e-23 5.879e-22
103 RESPONSE TO GROWTH FACTOR 59 475 1.461e-23 6.601e-22
104 LEUKOCYTE CELL CELL ADHESION 44 255 1.519e-23 6.796e-22
105 REGULATION OF DEFENSE RESPONSE 75 759 1.623e-23 7.193e-22
106 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 91 1087 2.482e-23 1.09e-21
107 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 58 465 2.887e-23 1.255e-21
108 NEUROGENESIS 105 1402 3.632e-23 1.565e-21
109 POSITIVE REGULATION OF PEPTIDASE ACTIVITY 35 154 4.275e-23 1.825e-21
110 BLOOD VESSEL MORPHOGENESIS 51 364 7.566e-23 3.2e-21
111 GLAND DEVELOPMENT 53 395 8.171e-23 3.425e-21
112 REGULATION OF RESPONSE TO WOUNDING 54 413 1.092e-22 4.535e-21
113 PROTEIN PHOSPHORYLATION 83 944 1.214e-22 5e-21
114 RESPONSE TO INORGANIC SUBSTANCE 58 479 1.297e-22 5.294e-21
115 MORPHOGENESIS OF AN EPITHELIUM 53 400 1.483e-22 5.998e-21
116 TAXIS 57 464 1.512e-22 6.065e-21
117 HOMEOSTATIC PROCESS 101 1337 1.545e-22 6.146e-21
118 REGULATION OF CELL ACTIVATION 58 484 2.188e-22 8.627e-21
119 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 83 957 2.95e-22 1.154e-20
120 POSITIVE REGULATION OF CELL ADHESION 51 376 3.362e-22 1.303e-20
121 CELL DEVELOPMENT 104 1426 4.653e-22 1.789e-20
122 AGING 43 264 5.197e-22 1.982e-20
123 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 69 689 5.471e-22 2.07e-20
124 PHOSPHORYLATION 95 1228 6.708e-22 2.517e-20
125 REGULATION OF PROTEIN LOCALIZATION 82 950 7.416e-22 2.761e-20
126 REGULATION OF CELLULAR LOCALIZATION 97 1277 8.514e-22 3.144e-20
127 CELLULAR RESPONSE TO NITROGEN COMPOUND 58 505 1.824e-21 6.681e-20
128 REGULATION OF GROWTH 65 633 2.529e-21 9.193e-20
129 REGULATION OF APOPTOTIC SIGNALING PATHWAY 49 363 2.845e-21 1.026e-19
130 REGULATION OF PROTEOLYSIS 69 711 3.201e-21 1.146e-19
131 RESPONSE TO DRUG 53 431 4.858e-21 1.725e-19
132 REGULATION OF IMMUNE RESPONSE 76 858 6.174e-21 2.176e-19
133 POSITIVE REGULATION OF CYTOKINE PRODUCTION 49 370 6.562e-21 2.296e-19
134 NEGATIVE REGULATION OF CELL DIFFERENTIATION 63 609 7.481e-21 2.598e-19
135 POSITIVE REGULATION OF MAPK CASCADE 55 470 8.887e-21 3.063e-19
136 LYMPHOCYTE DIFFERENTIATION 37 209 2.292e-20 7.841e-19
137 TUBE DEVELOPMENT 59 552 2.884e-20 9.795e-19
138 POSITIVE REGULATION OF KINASE ACTIVITY 55 482 2.911e-20 9.816e-19
139 REGULATION OF HOMOTYPIC CELL CELL ADHESION 44 307 3.097e-20 1.037e-18
140 CELL CELL ADHESION 62 608 3.264e-20 1.085e-18
141 SKELETAL SYSTEM DEVELOPMENT 53 455 5.823e-20 1.921e-18
142 INNATE IMMUNE RESPONSE 62 619 8.117e-20 2.66e-18
143 EMBRYO DEVELOPMENT 75 894 2.713e-19 8.829e-18
144 REPRODUCTION 93 1297 3.45e-19 1.115e-17
145 CELLULAR RESPONSE TO STRESS 104 1565 4.521e-19 1.451e-17
146 REGULATION OF EPITHELIAL CELL PROLIFERATION 41 285 5.461e-19 1.74e-17
147 REGULATION OF OSSIFICATION 33 178 6.235e-19 1.974e-17
148 CELL PROLIFERATION 63 672 1.152e-18 3.621e-17
149 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 52 470 1.299e-18 4.056e-17
150 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 60 616 1.311e-18 4.065e-17
151 REGULATION OF NEURON DEATH 38 252 2.153e-18 6.634e-17
152 RESPONSE TO OXYGEN LEVELS 42 311 2.192e-18 6.666e-17
153 POSITIVE REGULATION OF CELL ACTIVATION 42 311 2.192e-18 6.666e-17
154 REGULATION OF CYTOKINE SECRETION 30 149 2.229e-18 6.734e-17
155 HEART DEVELOPMENT 51 466 4.533e-18 1.361e-16
156 REGULATION OF CELLULAR RESPONSE TO STRESS 63 691 4.635e-18 1.383e-16
157 NEGATIVE REGULATION OF MOLECULAR FUNCTION 81 1079 6.874e-18 2.037e-16
158 POSITIVE REGULATION OF HYDROLASE ACTIVITY 73 905 7.607e-18 2.24e-16
159 REGULATION OF CELL CYCLE 75 949 7.991e-18 2.339e-16
160 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 47 404 8.722e-18 2.536e-16
161 ANGIOGENESIS 40 293 9.889e-18 2.858e-16
162 ZYMOGEN ACTIVATION 26 112 1.015e-17 2.915e-16
163 REPRODUCTIVE SYSTEM DEVELOPMENT 47 408 1.295e-17 3.697e-16
164 OSSIFICATION 37 251 1.322e-17 3.752e-16
165 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 40 296 1.424e-17 4.016e-16
166 CELLULAR RESPONSE TO HORMONE STIMULUS 55 552 1.452e-17 4.071e-16
167 RESPONSE TO MECHANICAL STIMULUS 34 210 1.474e-17 4.106e-16
168 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 65 750 1.701e-17 4.711e-16
169 POSITIVE REGULATION OF PROTEOLYSIS 44 363 2.16e-17 5.946e-16
170 ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 24 95 2.262e-17 6.192e-16
171 RESPONSE TO METAL ION 42 333 2.782e-17 7.569e-16
172 RESPONSE TO OXIDATIVE STRESS 43 352 3.795e-17 1.027e-15
173 REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 29 152 3.859e-17 1.038e-15
174 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 116 1977 3.885e-17 1.039e-15
175 CHEMICAL HOMEOSTASIS 70 874 5.696e-17 1.514e-15
176 MORPHOGENESIS OF A BRANCHING STRUCTURE 30 167 6.319e-17 1.671e-15
177 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 51 498 7.534e-17 1.98e-15
178 REGULATION OF NEURON DIFFERENTIATION 54 554 7.63e-17 1.995e-15
179 REGULATION OF HEMOPOIESIS 40 314 1.154e-16 3e-15
180 T CELL DIFFERENTIATION 26 123 1.203e-16 3.11e-15
181 POSITIVE REGULATION OF DEFENSE RESPONSE 43 364 1.317e-16 3.385e-15
182 REGULATION OF SECRETION 61 699 1.324e-16 3.386e-15
183 REGULATION OF BODY FLUID LEVELS 51 506 1.464e-16 3.723e-15
184 CYTOKINE MEDIATED SIGNALING PATHWAY 48 452 1.535e-16 3.882e-15
185 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 56 602 1.584e-16 3.983e-15
186 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 33 213 1.728e-16 4.324e-15
187 REGENERATION 29 161 1.95e-16 4.851e-15
188 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 47 437 1.968e-16 4.87e-15
189 RESPONSE TO ACID CHEMICAL 40 319 2.007e-16 4.916e-15
190 REGULATION OF MAP KINASE ACTIVITY 40 319 2.007e-16 4.916e-15
191 POSITIVE REGULATION OF CELL CELL ADHESION 35 243 2.138e-16 5.209e-15
192 GLIOGENESIS 30 175 2.423e-16 5.873e-15
193 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 51 514 2.806e-16 6.766e-15
194 REGULATION OF INFLAMMATORY RESPONSE 38 294 4.234e-16 1.016e-14
195 REGULATION OF NEURON APOPTOTIC PROCESS 31 192 4.401e-16 1.05e-14
196 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 26 131 6.145e-16 1.459e-14
197 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 61 724 6.866e-16 1.622e-14
198 REGULATION OF PROTEIN SECRETION 43 389 1.49e-15 3.502e-14
199 REGULATION OF LEUKOCYTE MIGRATION 27 149 1.85e-15 4.325e-14
200 CELL CHEMOTAXIS 28 162 1.967e-15 4.577e-14
201 REGULATION OF HOMEOSTATIC PROCESS 46 447 2.24e-15 5.185e-14
202 RESPONSE TO ESTROGEN 32 218 2.455e-15 5.654e-14
203 REGULATION OF INTRACELLULAR TRANSPORT 55 621 2.504e-15 5.74e-14
204 POSITIVE REGULATION OF IMMUNE RESPONSE 52 563 2.766e-15 6.309e-14
205 MUSCLE STRUCTURE DEVELOPMENT 45 432 2.924e-15 6.637e-14
206 PROTEIN MATURATION 35 265 3.258e-15 7.36e-14
207 POSITIVE REGULATION OF CELL DEVELOPMENT 47 472 3.861e-15 8.679e-14
208 PEPTIDYL AMINO ACID MODIFICATION 65 841 4.633e-15 1.036e-13
209 GLAND MORPHOGENESIS 22 97 5.74e-15 1.278e-13
210 CELLULAR HOMEOSTASIS 57 676 6.442e-15 1.427e-13
211 POSITIVE REGULATION OF CHEMOTAXIS 24 120 6.838e-15 1.508e-13
212 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 54 616 7.031e-15 1.543e-13
213 POSITIVE REGULATION OF LEUKOCYTE MIGRATION 23 109 7.374e-15 1.611e-13
214 REGULATION OF CYTOPLASMIC TRANSPORT 47 481 7.91e-15 1.72e-13
215 RESPONSE TO PURINE CONTAINING COMPOUND 27 158 8.428e-15 1.824e-13
216 TUBE MORPHOGENESIS 38 323 9.463e-15 2.039e-13
217 REGULATION OF INNATE IMMUNE RESPONSE 40 357 9.585e-15 2.055e-13
218 NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 30 200 1.027e-14 2.191e-13
219 POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 27 162 1.598e-14 3.394e-13
220 RESPONSE TO CORTICOSTEROID 28 176 1.756e-14 3.714e-13
221 REGULATION OF CELL MORPHOGENESIS 50 552 2.109e-14 4.44e-13
222 EPITHELIAL CELL DIFFERENTIATION 47 495 2.328e-14 4.879e-13
223 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 50 554 2.429e-14 5.068e-13
224 RESPONSE TO PEPTIDE 42 404 2.749e-14 5.711e-13
225 REGULATION OF CHEMOTAXIS 28 180 3.153e-14 6.496e-13
226 CONNECTIVE TISSUE DEVELOPMENT 29 194 3.155e-14 6.496e-13
227 LEUKOCYTE CHEMOTAXIS 23 117 3.718e-14 7.622e-13
228 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 49 541 3.916e-14 7.956e-13
229 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 49 541 3.916e-14 7.956e-13
230 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 56 684 3.947e-14 7.986e-13
231 RESPONSE TO KETONE 28 182 4.198e-14 8.457e-13
232 NEGATIVE REGULATION OF CYTOKINE PRODUCTION 30 211 4.44e-14 8.904e-13
233 CELL FATE COMMITMENT 31 227 5.113e-14 1.021e-12
234 POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 27 171 6.278e-14 1.248e-12
235 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 47 513 8.775e-14 1.737e-12
236 REGULATION OF ORGANELLE ORGANIZATION 77 1178 8.902e-14 1.755e-12
237 ACTIVATION OF PROTEIN KINASE ACTIVITY 34 279 8.983e-14 1.764e-12
238 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 39 365 9.852e-14 1.926e-12
239 CELLULAR RESPONSE TO EXTERNAL STIMULUS 33 264 1.013e-13 1.972e-12
240 CELLULAR RESPONSE TO ACID CHEMICAL 27 175 1.121e-13 2.173e-12
241 RHYTHMIC PROCESS 35 298 1.167e-13 2.253e-12
242 NEGATIVE REGULATION OF PHOSPHORYLATION 42 422 1.224e-13 2.353e-12
243 POSITIVE REGULATION OF RESPONSE TO WOUNDING 26 162 1.24e-13 2.374e-12
244 MESENCHYME DEVELOPMENT 28 190 1.27e-13 2.422e-12
245 EMBRYONIC MORPHOGENESIS 48 539 1.363e-13 2.58e-12
246 REGULATION OF BINDING 34 283 1.364e-13 2.58e-12
247 POSITIVE REGULATION OF HEMOPOIESIS 26 163 1.44e-13 2.712e-12
248 POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 39 370 1.528e-13 2.867e-12
249 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 24 138 1.779e-13 3.325e-12
250 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 25 153 2.425e-13 4.513e-12
251 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 23 129 3.301e-13 6.094e-12
252 REGULATION OF CELLULAR PROTEIN LOCALIZATION 48 552 3.297e-13 6.094e-12
253 MULTI MULTICELLULAR ORGANISM PROCESS 29 213 3.67e-13 6.749e-12
254 NEGATIVE REGULATION OF NEURON DEATH 26 171 4.57e-13 8.372e-12
255 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 24 144 4.691e-13 8.559e-12
256 REGULATION OF VASCULATURE DEVELOPMENT 30 233 6.311e-13 1.147e-11
257 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 33 282 6.627e-13 1.2e-11
258 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 29 218 6.682e-13 1.205e-11
259 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 20 98 8.347e-13 1.5e-11
260 CENTRAL NERVOUS SYSTEM DEVELOPMENT 62 872 8.629e-13 1.544e-11
261 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 36 337 9.125e-13 1.627e-11
262 REGULATION OF SYSTEM PROCESS 45 507 9.255e-13 1.644e-11
263 REGULATION OF LEUKOCYTE PROLIFERATION 28 206 9.818e-13 1.737e-11
264 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 60 829 9.862e-13 1.738e-11
265 POSITIVE REGULATION OF GROWTH 30 238 1.103e-12 1.929e-11
266 CELLULAR COMPONENT MORPHOGENESIS 63 900 1.1e-12 1.929e-11
267 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 20 100 1.246e-12 2.166e-11
268 NEGATIVE REGULATION OF CELL CYCLE 41 433 1.248e-12 2.166e-11
269 REGULATION OF DEVELOPMENTAL GROWTH 33 289 1.319e-12 2.273e-11
270 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 33 289 1.319e-12 2.273e-11
271 SENSORY ORGAN DEVELOPMENT 44 493 1.39e-12 2.387e-11
272 REGULATION OF MUSCLE CELL DIFFERENTIATION 24 152 1.582e-12 2.707e-11
273 MUSCLE TISSUE DEVELOPMENT 32 275 1.742e-12 2.968e-11
274 POSITIVE REGULATION OF PROTEIN SECRETION 28 211 1.785e-12 3.031e-11
275 IN UTERO EMBRYONIC DEVELOPMENT 34 311 2.073e-12 3.494e-11
276 HEMOSTASIS 34 311 2.073e-12 3.494e-11
277 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 21 115 2.194e-12 3.685e-11
278 REGULATION OF MUSCLE ORGAN DEVELOPMENT 20 103 2.229e-12 3.731e-11
279 REGULATION OF PROTEIN IMPORT 26 183 2.285e-12 3.811e-11
280 PROTEOLYSIS 75 1208 2.522e-12 4.192e-11
281 POSITIVE REGULATION OF PROTEIN IMPORT 20 104 2.693e-12 4.46e-11
282 CELLULAR RESPONSE TO ABIOTIC STIMULUS 31 263 2.776e-12 4.58e-11
283 REGULATION OF LEUKOCYTE DIFFERENTIATION 29 232 3.268e-12 5.373e-11
284 REGULATION OF FAT CELL DIFFERENTIATION 20 106 3.906e-12 6.4e-11
285 POSITIVE REGULATION OF OSSIFICATION 18 84 4.866e-12 7.945e-11
286 RESPONSE TO RADIATION 39 413 4.908e-12 7.985e-11
287 STEM CELL DIFFERENTIATION 26 190 5.496e-12 8.911e-11
288 REGULATION OF DNA METABOLIC PROCESS 35 340 5.546e-12 8.955e-11
289 POSITIVE REGULATION OF CYTOKINE SECRETION 19 96 5.562e-12 8.955e-11
290 REGULATION OF PROTEIN KINASE B SIGNALING 21 121 6.113e-12 9.809e-11
291 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 24 162 6.485e-12 1.037e-10
292 NEGATIVE REGULATION OF CELL ADHESION 28 223 6.968e-12 1.11e-10
293 COLLAGEN FIBRIL ORGANIZATION 13 38 7.038e-12 1.118e-10
294 NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 22 135 7.084e-12 1.121e-10
295 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 18 86 7.439e-12 1.173e-10
296 GLIAL CELL DIFFERENTIATION 22 136 8.248e-12 1.297e-10
297 NEURON DIFFERENTIATION 60 874 8.995e-12 1.409e-10
298 RESPONSE TO EXTRACELLULAR STIMULUS 40 441 9.184e-12 1.434e-10
299 REGULATION OF ORGAN MORPHOGENESIS 29 242 9.425e-12 1.467e-10
300 PROTEIN COMPLEX SUBUNIT ORGANIZATION 86 1527 9.511e-12 1.475e-10
301 PLACENTA DEVELOPMENT 22 138 1.113e-11 1.721e-10
302 HEART MORPHOGENESIS 27 212 1.189e-11 1.832e-10
303 RESPONSE TO ORGANOPHOSPHORUS 22 139 1.291e-11 1.983e-10
304 IMMUNE EFFECTOR PROCESS 42 486 1.304e-11 1.996e-10
305 REGULATION OF CELLULAR COMPONENT BIOGENESIS 55 767 1.354e-11 2.066e-10
306 CELLULAR CHEMICAL HOMEOSTASIS 46 570 1.41e-11 2.138e-10
307 DEVELOPMENTAL GROWTH 34 333 1.41e-11 2.138e-10
308 GROWTH 38 410 1.629e-11 2.461e-10
309 UROGENITAL SYSTEM DEVELOPMENT 32 299 1.653e-11 2.489e-10
310 REGULATION OF MUSCLE TISSUE DEVELOPMENT 19 103 2.053e-11 3.081e-10
311 RESPONSE TO INTERFERON GAMMA 22 144 2.653e-11 3.969e-10
312 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 35 360 2.799e-11 4.174e-10
313 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 27 220 2.841e-11 4.223e-10
314 MYELOID CELL DIFFERENTIATION 25 189 3.008e-11 4.458e-10
315 MUSCLE CELL DIFFERENTIATION 28 237 3.04e-11 4.491e-10
316 REGULATION OF PROTEIN TARGETING 32 307 3.318e-11 4.886e-10
317 REGULATION OF ERK1 AND ERK2 CASCADE 28 238 3.363e-11 4.936e-10
318 FAT CELL DIFFERENTIATION 19 106 3.474e-11 5.084e-10
319 POSITIVE REGULATION OF MAP KINASE ACTIVITY 26 207 3.934e-11 5.738e-10
320 MESENCHYMAL CELL DIFFERENTIATION 21 134 4.591e-11 6.675e-10
321 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 20 121 4.926e-11 7.14e-10
322 EMBRYONIC ORGAN DEVELOPMENT 37 406 4.956e-11 7.161e-10
323 MYELOID LEUKOCYTE DIFFERENTIATION 18 96 5.233e-11 7.515e-10
324 REGULATION OF LEUKOCYTE CHEMOTAXIS 18 96 5.233e-11 7.515e-10
325 INTERSPECIES INTERACTION BETWEEN ORGANISMS 49 662 6.378e-11 9.104e-10
326 SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM 49 662 6.378e-11 9.104e-10
327 POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 27 228 6.518e-11 9.274e-10
328 HEAD DEVELOPMENT 51 709 7.093e-11 1.006e-09
329 POSITIVE REGULATION OF INNATE IMMUNE RESPONSE 28 246 7.386e-11 1.045e-09
330 REGULATION OF MYELOID CELL DIFFERENTIATION 24 183 8.995e-11 1.268e-09
331 TISSUE REMODELING 17 87 9.079e-11 1.276e-09
332 REGULATION OF OSTEOBLAST DIFFERENTIATION 19 112 9.427e-11 1.321e-09
333 REGULATION OF CHEMOKINE PRODUCTION 15 65 9.586e-11 1.335e-09
334 REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 15 65 9.586e-11 1.335e-09
335 CELLULAR RESPONSE TO OXIDATIVE STRESS 24 184 1.01e-10 1.402e-09
336 AMEBOIDAL TYPE CELL MIGRATION 22 154 1.023e-10 1.416e-09
337 REGULATION OF STEM CELL DIFFERENTIATION 19 113 1.106e-10 1.527e-09
338 POSITIVE REGULATION OF BINDING 20 127 1.218e-10 1.677e-09
339 PEPTIDYL TYROSINE MODIFICATION 24 186 1.269e-10 1.741e-09
340 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 35 381 1.347e-10 1.843e-09
341 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 27 236 1.44e-10 1.965e-09
342 REGULATION OF METAL ION TRANSPORT 32 325 1.46e-10 1.986e-09
343 RESPONSE TO INTERLEUKIN 1 19 115 1.515e-10 2.055e-09
344 APOPTOTIC SIGNALING PATHWAY 30 289 1.531e-10 2.07e-09
345 EYE DEVELOPMENT 32 326 1.58e-10 2.13e-09
346 ACTIVATION OF INNATE IMMUNE RESPONSE 25 204 1.601e-10 2.153e-09
347 MULTI ORGANISM REPRODUCTIVE PROCESS 58 891 1.656e-10 2.221e-09
348 REGULATION OF RESPONSE TO CYTOKINE STIMULUS 21 144 1.842e-10 2.463e-09
349 REGULATION OF WNT SIGNALING PATHWAY 31 310 1.932e-10 2.575e-09
350 NEGATIVE REGULATION OF PROTEOLYSIS 32 329 1.998e-10 2.656e-09
351 ACTIVATION OF IMMUNE RESPONSE 37 427 2.095e-10 2.777e-09
352 HOMEOSTASIS OF NUMBER OF CELLS 23 175 2.13e-10 2.816e-09
353 POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 20 131 2.162e-10 2.85e-09
354 RESPONSE TO REACTIVE OXYGEN SPECIES 24 191 2.215e-10 2.912e-09
355 CELLULAR RESPONSE TO MECHANICAL STIMULUS 16 80 2.257e-10 2.958e-09
356 REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 19 118 2.397e-10 3.133e-09
357 POSITIVE REGULATION OF SECRETION 34 370 2.47e-10 3.219e-09
358 MUSCLE ORGAN DEVELOPMENT 29 277 2.541e-10 3.303e-09
359 CARTILAGE DEVELOPMENT 21 147 2.729e-10 3.528e-09
360 REGULATION OF CELL GROWTH 35 391 2.73e-10 3.528e-09
361 POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING 16 81 2.745e-10 3.529e-09
362 POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS 16 81 2.745e-10 3.529e-09
363 NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS 34 372 2.85e-10 3.654e-09
364 REGULATION OF CELL PROJECTION ORGANIZATION 43 558 2.896e-10 3.702e-09
365 RESPONSE TO TRANSITION METAL NANOPARTICLE 21 148 3.104e-10 3.956e-09
366 CYTOKINE PRODUCTION 19 120 3.228e-10 4.104e-09
367 REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS 17 94 3.262e-10 4.136e-09
368 CELL CYCLE PROCESS 65 1081 3.305e-10 4.179e-09
369 RESPONSE TO PROGESTERONE 13 50 3.459e-10 4.362e-09
370 LEUKOCYTE HOMEOSTASIS 14 60 3.471e-10 4.365e-09
371 ORGAN REGENERATION 16 83 4.026e-10 5.036e-09
372 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 37 437 4.019e-10 5.036e-09
373 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 24 197 4.219e-10 5.25e-09
374 POSITIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY 24 197 4.219e-10 5.25e-09
375 CELLULAR RESPONSE TO INTERFERON GAMMA 19 122 4.322e-10 5.362e-09
376 CARDIOCYTE DIFFERENTIATION 17 96 4.6e-10 5.693e-09
377 FORMATION OF PRIMARY GERM LAYER 18 110 5.436e-10 6.709e-09
378 POSITIVE REGULATION OF HOMEOSTATIC PROCESS 25 216 5.453e-10 6.712e-09
379 NEGATIVE REGULATION OF CELL CELL ADHESION 20 138 5.606e-10 6.883e-09
380 POSITIVE REGULATION OF NEURON DIFFERENTIATION 30 306 6.149e-10 7.53e-09
381 POSITIVE REGULATION OF DNA METABOLIC PROCESS 23 185 6.531e-10 7.976e-09
382 CELL CYCLE ARREST 21 154 6.568e-10 8e-09
383 CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 25 218 6.63e-10 8.055e-09
384 ENDOCYTOSIS 40 509 7.025e-10 8.512e-09
385 BONE DEVELOPMENT 21 156 8.363e-10 1.008e-08
386 CELLULAR RESPONSE TO INORGANIC SUBSTANCE 21 156 8.363e-10 1.008e-08
387 POSITIVE REGULATION OF INFLAMMATORY RESPONSE 18 113 8.551e-10 1.028e-08
388 CELL CYCLE 73 1316 8.783e-10 1.053e-08
389 PLATELET ACTIVATION 20 142 9.404e-10 1.125e-08
390 NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 16 88 9.992e-10 1.189e-08
391 POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 16 88 9.992e-10 1.189e-08
392 EXTRACELLULAR MATRIX DISASSEMBLY 15 76 1.007e-09 1.196e-08
393 REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 17 101 1.046e-09 1.238e-08
394 POSITIVE REGULATION OF CELL CYCLE 31 332 1.053e-09 1.244e-08
395 MULTICELLULAR ORGANISM REPRODUCTION 51 768 1.164e-09 1.371e-08
396 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 24 207 1.168e-09 1.373e-08
397 RESPONSE TO IONIZING RADIATION 20 145 1.369e-09 1.601e-08
398 NEGATIVE REGULATION OF MAPK CASCADE 20 145 1.369e-09 1.601e-08
399 REGULATION OF PROTEIN COMPLEX ASSEMBLY 33 375 1.382e-09 1.611e-08
400 REGULATION OF CALCIUM ION TRANSPORT 24 209 1.421e-09 1.653e-08
401 MAMMARY GLAND DEVELOPMENT 18 117 1.529e-09 1.774e-08
402 REGULATION OF CYTOSKELETON ORGANIZATION 39 502 1.603e-09 1.855e-08
403 CELL AGING 14 67 1.655e-09 1.911e-08
404 RESPONSE TO CAMP 17 104 1.671e-09 1.925e-08
405 SKIN DEVELOPMENT 24 211 1.725e-09 1.982e-08
406 REGULATION OF LIPID METABOLIC PROCESS 28 282 1.739e-09 1.993e-08
407 REGULATION OF T CELL PROLIFERATION 20 147 1.75e-09 2e-08
408 BONE MORPHOGENESIS 15 79 1.779e-09 2.029e-08
409 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 25 229 1.865e-09 2.122e-08
410 RESPONSE TO VIRUS 26 247 1.934e-09 2.195e-08
411 POSITIVE REGULATION OF CELL GROWTH 20 148 1.974e-09 2.235e-08
412 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN 14 68 2.035e-09 2.298e-08
413 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 29 303 2.083e-09 2.346e-08
414 REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 11 38 2.282e-09 2.565e-08
415 REGULATION OF INTERLEUKIN 1 PRODUCTION 13 58 2.54e-09 2.848e-08
416 REGULATION OF MITOTIC CELL CYCLE 37 468 2.658e-09 2.973e-08
417 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 34 406 2.789e-09 3.108e-08
418 ADAPTIVE IMMUNE RESPONSE 28 288 2.792e-09 3.108e-08
419 POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION 19 136 2.845e-09 3.159e-08
420 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 18 122 3.053e-09 3.382e-08
421 REGULATION OF NEURON PROJECTION DEVELOPMENT 34 408 3.162e-09 3.494e-08
422 REGULATION OF PROTEIN BINDING 21 168 3.291e-09 3.62e-08
423 RESPONSE TO CARBOHYDRATE 21 168 3.291e-09 3.62e-08
424 REGULATION OF ANATOMICAL STRUCTURE SIZE 37 472 3.347e-09 3.673e-08
425 ENDOCRINE SYSTEM DEVELOPMENT 18 123 3.491e-09 3.822e-08
426 PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY 17 109 3.518e-09 3.841e-08
427 POSITIVE REGULATION OF CHEMOKINE PRODUCTION 12 49 3.525e-09 3.841e-08
428 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 13 60 3.965e-09 4.3e-08
429 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 13 60 3.965e-09 4.3e-08
430 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 12 50 4.529e-09 4.901e-08
431 NEGATIVE REGULATION OF TRANSPORT 36 458 5.111e-09 5.518e-08
432 RESPONSE TO VITAMIN 16 98 5.139e-09 5.535e-08
433 REGULATION OF WOUND HEALING 18 126 5.175e-09 5.561e-08
434 RESPONSE TO AMINO ACID 17 112 5.388e-09 5.777e-08
435 POSITIVE REGULATION OF STAT CASCADE 14 73 5.415e-09 5.779e-08
436 POSITIVE REGULATION OF JAK STAT CASCADE 14 73 5.415e-09 5.779e-08
437 REGULATION OF ION TRANSPORT 42 592 5.538e-09 5.896e-08
438 REGULATION OF VITAMIN METABOLIC PROCESS 7 12 5.756e-09 6.115e-08
439 EXTRINSIC APOPTOTIC SIGNALING PATHWAY 16 99 5.984e-09 6.342e-08
440 RESPONSE TO NUTRIENT 22 191 6.523e-09 6.898e-08
441 MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 15 87 7.163e-09 7.457e-08
442 ENTRY INTO CELL OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 15 87 7.163e-09 7.457e-08
443 VIRAL ENTRY INTO HOST CELL 15 87 7.163e-09 7.457e-08
444 ENTRY INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 15 87 7.163e-09 7.457e-08
445 MOVEMENT IN HOST ENVIRONMENT 15 87 7.163e-09 7.457e-08
446 ENTRY INTO HOST 15 87 7.163e-09 7.457e-08
447 ENTRY INTO HOST CELL 15 87 7.163e-09 7.457e-08
448 POSITIVE REGULATION OF DNA BINDING 11 42 7.383e-09 7.668e-08
449 REGULATION OF CARTILAGE DEVELOPMENT 13 63 7.476e-09 7.748e-08
450 REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 14 75 7.826e-09 8.092e-08
451 CELLULAR RESPONSE TO ALCOHOL 17 115 8.136e-09 8.393e-08
452 NEGATIVE REGULATION OF CELL DEVELOPMENT 28 303 8.606e-09 8.859e-08
453 CELL CELL SIGNALING 49 767 8.829e-09 9.069e-08
454 REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS 12 53 9.267e-09 9.497e-08
455 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 16 102 9.338e-09 9.55e-08
456 RESPONSE TO ESTRADIOL 19 146 9.447e-09 9.64e-08
457 REGULATION OF MUSCLE SYSTEM PROCESS 22 195 9.592e-09 9.766e-08
458 CELLULAR COMPONENT DISASSEMBLY 38 515 1.066e-08 1.083e-07
459 CIRCULATORY SYSTEM PROCESS 31 366 1.086e-08 1.101e-07
460 REGULATION OF LYMPHOCYTE DIFFERENTIATION 18 132 1.099e-08 1.112e-07
461 RESPONSE TO TUMOR NECROSIS FACTOR 24 233 1.247e-08 1.259e-07
462 NEGATIVE REGULATION OF MITOTIC CELL CYCLE 22 199 1.396e-08 1.406e-07
463 MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS 14 79 1.578e-08 1.585e-07
464 REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 15 92 1.581e-08 1.585e-07
465 REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 11 45 1.631e-08 1.632e-07
466 POSITIVE REGULATION OF NEURON DEATH 13 67 1.647e-08 1.641e-07
467 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 13 67 1.647e-08 1.641e-07
468 REGULATION OF ION HOMEOSTASIS 22 201 1.678e-08 1.668e-07
469 CELLULAR RESPONSE TO PEPTIDE 26 274 1.709e-08 1.692e-07
470 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 26 274 1.709e-08 1.692e-07
471 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 17 121 1.783e-08 1.761e-07
472 MULTICELLULAR ORGANISM METABOLIC PROCESS 15 93 1.84e-08 1.814e-07
473 NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 14 80 1.867e-08 1.837e-07
474 DEFENSE RESPONSE TO OTHER ORGANISM 37 505 2.015e-08 1.978e-07
475 POSITIVE REGULATION OF ORGANELLE ORGANIZATION 40 573 2.029e-08 1.987e-07
476 NEGATIVE REGULATION OF HYDROLASE ACTIVITY 32 397 2.052e-08 2.005e-07
477 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 19 154 2.292e-08 2.236e-07
478 ION HOMEOSTASIS 40 576 2.341e-08 2.279e-07
479 RESPONSE TO HYDROGEN PEROXIDE 16 109 2.481e-08 2.41e-07
480 CELLULAR RESPONSE TO DNA DAMAGE STIMULUS 46 720 2.581e-08 2.502e-07
481 INOSITOL LIPID MEDIATED SIGNALING 17 124 2.591e-08 2.506e-07
482 THYMUS DEVELOPMENT 11 47 2.668e-08 2.576e-07
483 POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE 20 172 2.709e-08 2.61e-07
484 INTERFERON GAMMA MEDIATED SIGNALING PATHWAY 13 70 2.867e-08 2.757e-07
485 STRIATED MUSCLE CELL DIFFERENTIATION 20 173 2.99e-08 2.868e-07
486 NEGATIVE REGULATION OF PEPTIDASE ACTIVITY 24 245 3.308e-08 3.167e-07
487 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 11 48 3.381e-08 3.23e-07
488 NEGATIVE REGULATION OF CELL ACTIVATION 19 158 3.491e-08 3.329e-07
489 REGULATION OF CATABOLIC PROCESS 46 731 4.06e-08 3.863e-07
490 CHONDROCYTE DIFFERENTIATION 12 60 4.114e-08 3.907e-07
491 SYSTEM PROCESS 85 1785 4.296e-08 4.071e-07
492 REGULATION OF JAK STAT CASCADE 18 144 4.375e-08 4.129e-07
493 REGULATION OF STAT CASCADE 18 144 4.375e-08 4.129e-07
494 ACUTE INFLAMMATORY RESPONSE 13 73 4.851e-08 4.56e-07
495 REGULATION OF ORGAN GROWTH 13 73 4.851e-08 4.56e-07
496 REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY 18 145 4.875e-08 4.564e-07
497 REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS 18 145 4.875e-08 4.564e-07
498 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 23 232 5.128e-08 4.791e-07
499 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 19 162 5.245e-08 4.891e-07
500 LYMPHOCYTE HOMEOSTASIS 11 50 5.33e-08 4.96e-07
501 CYTOSKELETON ORGANIZATION 50 838 5.476e-08 5.085e-07
502 REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING 23 233 5.553e-08 5.147e-07
503 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 21 197 5.629e-08 5.207e-07
504 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 13 74 5.746e-08 5.305e-07
505 REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 15 101 5.782e-08 5.327e-07
506 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 12 62 6.056e-08 5.569e-07
507 LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY 9 31 6.551e-08 6.013e-07
508 CELLULAR RESPONSE TO INTERLEUKIN 1 14 88 6.573e-08 6.021e-07
509 NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION 15 102 6.618e-08 6.05e-07
510 POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY 17 132 6.648e-08 6.054e-07
511 REGULATION OF INTERLEUKIN 12 PRODUCTION 11 51 6.637e-08 6.054e-07
512 NEGATIVE REGULATION OF GROWTH 23 236 7.032e-08 6.39e-07
513 REGULATION OF EPIDERMIS DEVELOPMENT 12 63 7.305e-08 6.626e-07
514 NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 10 41 7.559e-08 6.843e-07
515 DEFENSE RESPONSE TO BACTERIUM 23 237 7.601e-08 6.867e-07
516 SKELETAL SYSTEM MORPHOGENESIS 21 201 7.971e-08 7.188e-07
517 TISSUE REGENERATION 11 52 8.22e-08 7.384e-07
518 POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 11 52 8.22e-08 7.384e-07
519 INTERACTION WITH HOST 17 134 8.319e-08 7.458e-07
520 REGULATION OF INTERLEUKIN 6 PRODUCTION 15 104 8.627e-08 7.719e-07
521 CELL PROJECTION ORGANIZATION 52 902 8.779e-08 7.84e-07
522 REGULATION OF OXIDOREDUCTASE ACTIVITY 14 90 8.805e-08 7.849e-07
523 POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 24 258 8.862e-08 7.884e-07
524 NEGATIVE REGULATION OF CATABOLIC PROCESS 21 203 9.452e-08 8.394e-07
525 REGULATION OF IMMUNE EFFECTOR PROCESS 32 424 9.494e-08 8.414e-07
526 EPITHELIAL CELL DEVELOPMENT 20 186 1.009e-07 8.928e-07
527 POSITIVE REGULATION OF FIBROBLAST PROLIFERATION 11 53 1.013e-07 8.928e-07
528 CELLULAR RESPONSE TO AMINO ACID STIMULUS 11 53 1.013e-07 8.928e-07
529 RESPONSE TO ETHANOL 17 136 1.036e-07 9.116e-07
530 RENAL TUBULE DEVELOPMENT 13 78 1.1e-07 9.659e-07
531 POSITIVE REGULATION OF CALCIUM ION TRANSPORT 15 106 1.117e-07 9.791e-07
532 GLUCOSE HOMEOSTASIS 19 170 1.14e-07 9.948e-07
533 CARBOHYDRATE HOMEOSTASIS 19 170 1.14e-07 9.948e-07
534 CIRCADIAN RHYTHM 17 137 1.155e-07 1.006e-06
535 DIVALENT INORGANIC CATION HOMEOSTASIS 28 343 1.221e-07 1.062e-06
536 ALPHA BETA T CELL ACTIVATION 11 54 1.242e-07 1.079e-06
537 REGULATION OF DNA BINDING 14 93 1.345e-07 1.165e-06
538 GASTRULATION 18 155 1.369e-07 1.184e-06
539 NEURON PROJECTION DEVELOPMENT 37 545 1.414e-07 1.221e-06
540 CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 17 139 1.43e-07 1.232e-06
541 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 20 190 1.435e-07 1.234e-06
542 POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION 13 80 1.499e-07 1.287e-06
543 NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 11 55 1.517e-07 1.297e-06
544 REGULATION OF KIDNEY DEVELOPMENT 11 55 1.517e-07 1.297e-06
545 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 9 34 1.589e-07 1.357e-06
546 TELENCEPHALON DEVELOPMENT 22 228 1.613e-07 1.375e-06
547 POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION 13 81 1.744e-07 1.483e-06
548 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 14 95 1.766e-07 1.5e-06
549 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 11 56 1.843e-07 1.56e-06
550 OUTFLOW TRACT MORPHOGENESIS 11 56 1.843e-07 1.56e-06
551 ALPHA BETA T CELL DIFFERENTIATION 10 45 1.958e-07 1.653e-06
552 NEGATIVE REGULATION OF TRANSFERASE ACTIVITY 28 351 1.968e-07 1.659e-06
553 NEGATIVE REGULATION OF OSSIFICATION 12 69 2.092e-07 1.76e-06
554 EAR DEVELOPMENT 20 195 2.197e-07 1.845e-06
555 REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 11 57 2.231e-07 1.867e-06
556 ENDOTHELIAL CELL MIGRATION 11 57 2.231e-07 1.867e-06
557 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 10 46 2.443e-07 2.037e-06
558 REGULATION OF CHONDROCYTE DIFFERENTIATION 10 46 2.443e-07 2.037e-06
559 HEPATICOBILIARY SYSTEM DEVELOPMENT 16 128 2.456e-07 2.041e-06
560 POSITIVE REGULATION OF LIPID METABOLIC PROCESS 16 128 2.456e-07 2.041e-06
561 EPIDERMIS DEVELOPMENT 23 253 2.488e-07 2.064e-06
562 POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING 19 179 2.579e-07 2.135e-06
563 RESPIRATORY SYSTEM DEVELOPMENT 20 197 2.594e-07 2.144e-06
564 LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE 14 98 2.624e-07 2.165e-06
565 CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS 11 58 2.689e-07 2.21e-06
566 UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS 11 58 2.689e-07 2.21e-06
567 TISSUE MIGRATION 13 84 2.706e-07 2.221e-06
568 REGULATION OF ERYTHROCYTE DIFFERENTIATION 9 36 2.722e-07 2.226e-06
569 REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 9 36 2.722e-07 2.226e-06
570 REGULATION OF ENDOCYTOSIS 20 199 3.056e-07 2.495e-06
571 REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 13 85 3.119e-07 2.537e-06
572 TOLL LIKE RECEPTOR SIGNALING PATHWAY 13 85 3.119e-07 2.537e-06
573 NEPHRON DEVELOPMENT 15 115 3.327e-07 2.702e-06
574 GLIAL CELL MIGRATION 9 37 3.514e-07 2.849e-06
575 POSITIVE REGULATION OF DNA REPLICATION 13 86 3.588e-07 2.903e-06
576 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 10 48 3.741e-07 3.022e-06
577 MAINTENANCE OF CELL NUMBER 16 132 3.764e-07 3.036e-06
578 POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE 12 73 3.968e-07 3.194e-06
579 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 16 133 4.178e-07 3.357e-06
580 RESPONSE TO TOXIC SUBSTANCE 22 241 4.224e-07 3.389e-06
581 NEGATIVE REGULATION OF ORGANELLE ORGANIZATION 29 387 4.428e-07 3.546e-06
582 CELLULAR RESPONSE TO HYDROGEN PEROXIDE 11 61 4.599e-07 3.658e-06
583 REGULATION OF INTERLEUKIN 8 PRODUCTION 11 61 4.599e-07 3.658e-06
584 REGULATION OF STEROID BIOSYNTHETIC PROCESS 10 49 4.59e-07 3.658e-06
585 LYMPHOCYTE MIGRATION 10 49 4.59e-07 3.658e-06
586 CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS 12 74 4.625e-07 3.66e-06
587 CARDIAC MUSCLE CELL DIFFERENTIATION 12 74 4.625e-07 3.66e-06
588 NEGATIVE REGULATION OF CARDIAC MUSCLE CELL APOPTOTIC PROCESS 6 13 4.613e-07 3.66e-06
589 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 23 262 4.634e-07 3.661e-06
590 PARTURITION 7 20 4.694e-07 3.696e-06
591 REGULATION OF MONOCYTE CHEMOTAXIS 7 20 4.694e-07 3.696e-06
592 REGULATION OF COAGULATION 13 88 4.719e-07 3.703e-06
593 REGULATION OF STEM CELL PROLIFERATION 13 88 4.719e-07 3.703e-06
594 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 14 103 4.91e-07 3.846e-06
595 RESPONSE TO INSULIN 20 205 4.932e-07 3.851e-06
596 NEURON PROJECTION GUIDANCE 20 205 4.932e-07 3.851e-06
597 ARTERY DEVELOPMENT 12 75 5.376e-07 4.183e-06
598 NEURAL CREST CELL DIFFERENTIATION 12 75 5.376e-07 4.183e-06
599 EPITHELIAL CELL PROLIFERATION 13 89 5.396e-07 4.191e-06
600 CARDIAC CHAMBER MORPHOGENESIS 14 104 5.539e-07 4.278e-06
601 CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS 19 188 5.534e-07 4.278e-06
602 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 8 29 5.562e-07 4.278e-06
603 REGULATION OF HEART MORPHOGENESIS 8 29 5.562e-07 4.278e-06
604 POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 8 29 5.562e-07 4.278e-06
605 CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES 14 104 5.539e-07 4.278e-06
606 REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 10 50 5.605e-07 4.282e-06
607 STAT CASCADE 10 50 5.605e-07 4.282e-06
608 JAK STAT CASCADE 10 50 5.605e-07 4.282e-06
609 RESPONSE TO GAMMA RADIATION 10 50 5.605e-07 4.282e-06
610 EYE MORPHOGENESIS 16 136 5.675e-07 4.329e-06
611 REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN 9 39 5.714e-07 4.344e-06
612 ASTROCYTE DIFFERENTIATION 9 39 5.714e-07 4.344e-06
613 PALLIUM DEVELOPMENT 17 153 5.746e-07 4.361e-06
614 ODONTOGENESIS 14 105 6.24e-07 4.729e-06
615 ENDOCRINE PANCREAS DEVELOPMENT 9 40 7.203e-07 5.441e-06
616 ENDODERMAL CELL DIFFERENTIATION 9 40 7.203e-07 5.441e-06
617 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 17 156 7.574e-07 5.702e-06
618 NEGATIVE REGULATION OF RESPONSE TO WOUNDING 17 156 7.574e-07 5.702e-06
619 REGULATION OF PHOSPHOLIPASE ACTIVITY 11 64 7.619e-07 5.727e-06
620 REGULATION OF SEQUESTERING OF CALCIUM ION 14 107 7.886e-07 5.887e-06
621 POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS 6 14 7.894e-07 5.887e-06
622 REGULATION OF T CELL DIFFERENTIATION 14 107 7.886e-07 5.887e-06
623 T CELL MIGRATION 6 14 7.894e-07 5.887e-06
624 POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 6 14 7.894e-07 5.887e-06
625 PROTEIN COMPLEX BIOGENESIS 58 1132 8.002e-07 5.948e-06
626 PROTEIN COMPLEX ASSEMBLY 58 1132 8.002e-07 5.948e-06
627 POSITIVE REGULATION OF MITOTIC CELL CYCLE 15 123 8.034e-07 5.962e-06
628 CARDIAC MUSCLE TISSUE DEVELOPMENT 16 140 8.422e-07 6.24e-06
629 CELLULAR RESPONSE TO RETINOIC ACID 11 65 8.957e-07 6.626e-06
630 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 9 41 9.016e-07 6.627e-06
631 AORTA DEVELOPMENT 9 41 9.016e-07 6.627e-06
632 NEGATIVE REGULATION OF STRESS ACTIVATED MAPK CASCADE 9 41 9.016e-07 6.627e-06
633 NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 9 41 9.016e-07 6.627e-06
634 NEURON DEVELOPMENT 41 687 9.075e-07 6.629e-06
635 NEPHRON EPITHELIUM DEVELOPMENT 13 93 9.055e-07 6.629e-06
636 POSITIVE REGULATION OF BLOOD CIRCULATION 13 93 9.055e-07 6.629e-06
637 BEHAVIOR 34 516 9.063e-07 6.629e-06
638 FOREBRAIN DEVELOPMENT 27 357 9.259e-07 6.753e-06
639 REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 12 79 9.584e-07 6.979e-06
640 NEURON PROJECTION MORPHOGENESIS 29 402 9.647e-07 7.014e-06
641 REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY 7 22 9.867e-07 7.129e-06
642 REGULATION OF RESPONSE TO INTERFERON GAMMA 7 22 9.867e-07 7.129e-06
643 REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS 7 22 9.867e-07 7.129e-06
644 AORTA MORPHOGENESIS 7 22 9.867e-07 7.129e-06
645 KIDNEY EPITHELIUM DEVELOPMENT 15 125 9.899e-07 7.14e-06
646 REGULATION OF JNK CASCADE 17 159 9.913e-07 7.14e-06
647 MESODERM MORPHOGENESIS 11 66 1.05e-06 7.549e-06
648 MEMBRANE ORGANIZATION 49 899 1.088e-06 7.813e-06
649 OSTEOBLAST DIFFERENTIATION 15 126 1.097e-06 7.865e-06
650 REGULATION OF HEART GROWTH 9 42 1.121e-06 8.025e-06
651 POSITIVE REGULATION OF T CELL PROLIFERATION 13 95 1.161e-06 8.296e-06
652 POSITIVE REGULATION OF ION TRANSPORT 21 236 1.172e-06 8.363e-06
653 REGULATION OF DNA REPLICATION 17 161 1.182e-06 8.421e-06
654 POSITIVE REGULATION OF CALCIUM ION IMPORT 10 54 1.189e-06 8.457e-06
655 SINGLE ORGANISM BEHAVIOR 28 384 1.203e-06 8.547e-06
656 METANEPHROS DEVELOPMENT 12 81 1.262e-06 8.939e-06
657 REGULATION OF FIBROBLAST PROLIFERATION 12 81 1.262e-06 8.939e-06
658 SALIVARY GLAND DEVELOPMENT 8 32 1.272e-06 8.967e-06
659 POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT 8 32 1.272e-06 8.967e-06
660 NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 8 32 1.272e-06 8.967e-06
661 REGULATION OF LIPID BIOSYNTHETIC PROCESS 15 128 1.343e-06 9.454e-06
662 RESPONSE TO INCREASED OXYGEN LEVELS 7 23 1.386e-06 9.672e-06
663 REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 9 43 1.385e-06 9.672e-06
664 EMBRYONIC ORGAN MORPHOGENESIS 23 279 1.386e-06 9.672e-06
665 LEUKOCYTE APOPTOTIC PROCESS 7 23 1.386e-06 9.672e-06
666 RESPONSE TO HYPEROXIA 7 23 1.386e-06 9.672e-06
667 ACUTE PHASE RESPONSE 9 43 1.385e-06 9.672e-06
668 VASCULAR PROCESS IN CIRCULATORY SYSTEM 17 163 1.405e-06 9.785e-06
669 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 10 55 1.419e-06 9.855e-06
670 CRANIAL SKELETAL SYSTEM DEVELOPMENT 10 55 1.419e-06 9.855e-06
671 NEGATIVE REGULATION OF SECRETION 19 200 1.422e-06 9.861e-06
672 POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION 11 68 1.429e-06 9.896e-06
673 SENSORY ORGAN MORPHOGENESIS 21 239 1.438e-06 9.939e-06
674 KIDNEY MORPHOGENESIS 12 82 1.444e-06 9.968e-06
675 REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL 23 280 1.474e-06 1.016e-05
676 REGULATION OF MUSCLE CONTRACTION 16 147 1.624e-06 1.117e-05
677 CELLULAR SENESCENCE 8 33 1.641e-06 1.128e-05
678 EMBRYONIC PLACENTA DEVELOPMENT 12 83 1.648e-06 1.131e-05
679 POSITIVE REGULATION OF AXONOGENESIS 11 69 1.661e-06 1.138e-05
680 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 13 98 1.664e-06 1.139e-05
681 EPITHELIAL TO MESENCHYMAL TRANSITION 10 56 1.688e-06 1.153e-05
682 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 9 44 1.701e-06 1.159e-05
683 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN 9 44 1.701e-06 1.159e-05
684 POSITIVE REGULATION OF ENDOCYTOSIS 14 114 1.714e-06 1.166e-05
685 PEPTIDYL SERINE MODIFICATION 16 148 1.777e-06 1.205e-05
686 DIGESTIVE SYSTEM DEVELOPMENT 16 148 1.777e-06 1.205e-05
687 MYELOID LEUKOCYTE MIGRATION 13 99 1.87e-06 1.265e-05
688 LIPID PHOSPHORYLATION 13 99 1.87e-06 1.265e-05
689 POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 12 84 1.878e-06 1.268e-05
690 REGULATION OF CELL CYCLE PROCESS 35 558 1.929e-06 1.301e-05
691 CIRCADIAN REGULATION OF GENE EXPRESSION 10 57 1.999e-06 1.344e-05
692 POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 10 57 1.999e-06 1.344e-05
693 EXOCRINE SYSTEM DEVELOPMENT 9 45 2.078e-06 1.395e-05
694 PROTEIN KINASE B SIGNALING 8 34 2.097e-06 1.404e-05
695 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 8 34 2.097e-06 1.404e-05
696 INTRACELLULAR RECEPTOR SIGNALING PATHWAY 17 168 2.137e-06 1.427e-05
697 POSITIVE REGULATION OF CELL CYCLE ARREST 12 85 2.135e-06 1.427e-05
698 INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 11 71 2.224e-06 1.482e-05
699 NEGATIVE REGULATION OF CYTOKINE SECRETION 9 46 2.524e-06 1.68e-05
700 REGULATION OF CATION TRANSMEMBRANE TRANSPORT 19 208 2.557e-06 1.7e-05
701 CHEMOKINE MEDIATED SIGNALING PATHWAY 11 72 2.564e-06 1.702e-05
702 NEGATIVE REGULATION OF PROTEIN PROCESSING 8 35 2.656e-06 1.758e-05
703 NEGATIVE REGULATION OF PROTEIN MATURATION 8 35 2.656e-06 1.758e-05
704 REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 10 59 2.775e-06 1.834e-05
705 NEGATIVE REGULATION OF KINASE ACTIVITY 21 250 2.952e-06 1.94e-05
706 REGULATION OF CALCIUM ION IMPORT 13 103 2.942e-06 1.94e-05
707 CELLULAR RESPONSE TO KETONE 11 73 2.948e-06 1.94e-05
708 REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 11 73 2.948e-06 1.94e-05
709 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 18 191 3.008e-06 1.972e-05
710 ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS 16 154 3.006e-06 1.972e-05
711 NEGATIVE REGULATION OF ANOIKIS 6 17 3.042e-06 1.985e-05
712 POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY 9 47 3.049e-06 1.985e-05
713 POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY 6 17 3.042e-06 1.985e-05
714 POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS 9 47 3.049e-06 1.985e-05
715 NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS 6 17 3.042e-06 1.985e-05
716 MYELOID CELL HOMEOSTASIS 12 88 3.104e-06 2.017e-05
717 VESICLE MEDIATED TRANSPORT 60 1239 3.152e-06 2.046e-05
718 RESPONSE TO ALKALOID 15 137 3.179e-06 2.055e-05
719 SKELETAL MUSCLE ORGAN DEVELOPMENT 15 137 3.179e-06 2.055e-05
720 ACTIVATION OF MAPK ACTIVITY 15 137 3.179e-06 2.055e-05
721 REGULATION OF SMOOTH MUSCLE CONTRACTION 10 60 3.253e-06 2.099e-05
722 NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 8 36 3.337e-06 2.147e-05
723 T CELL SELECTION 8 36 3.337e-06 2.147e-05
724 DEVELOPMENTAL PROGRAMMED CELL DEATH 7 26 3.475e-06 2.233e-05
725 RESPONSE TO HEAT 12 89 3.504e-06 2.246e-05
726 B CELL DIFFERENTIATION 12 89 3.504e-06 2.246e-05
727 REGULATION OF B CELL ACTIVATION 14 121 3.512e-06 2.248e-05
728 NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS 16 156 3.56e-06 2.272e-05
729 POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS 16 156 3.56e-06 2.272e-05
730 CEREBRAL CORTEX DEVELOPMENT 13 105 3.659e-06 2.332e-05
731 REGULATION OF INTERLEUKIN 1 BETA PRODUCTION 9 48 3.667e-06 2.334e-05
732 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL 11 75 3.871e-06 2.46e-05
733 NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY 12 90 3.948e-06 2.503e-05
734 MESONEPHROS DEVELOPMENT 12 90 3.948e-06 2.503e-05
735 MYOBLAST DIFFERENTIATION 8 37 4.16e-06 2.63e-05
736 POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN 8 37 4.16e-06 2.63e-05
737 REGULATION OF ADAPTIVE IMMUNE RESPONSE 14 123 4.268e-06 2.694e-05
738 REGULATION OF SMOOTH MUSCLE CELL MIGRATION 9 49 4.389e-06 2.767e-05
739 RESPONSE TO PLATELET DERIVED GROWTH FACTOR 6 18 4.463e-06 2.81e-05
740 RESPONSE TO RETINOIC ACID 13 107 4.527e-06 2.846e-05
741 DETECTION OF BIOTIC STIMULUS 7 27 4.585e-06 2.875e-05
742 REGULATION OF CATENIN IMPORT INTO NUCLEUS 7 27 4.585e-06 2.875e-05
743 POSITIVE REGULATION OF HAIR CYCLE 5 11 4.911e-06 3.075e-05
744 REGULATION OF CELL CYCLE ARREST 13 108 5.025e-06 3.143e-05
745 REGULATION OF BMP SIGNALING PATHWAY 11 77 5.037e-06 3.146e-05
746 REGULATION OF MUSCLE ADAPTATION 10 63 5.14e-06 3.206e-05
747 LYMPHOCYTE CHEMOTAXIS 8 38 5.15e-06 3.208e-05
748 ENDODERM FORMATION 9 50 5.229e-06 3.253e-05
749 CELLULAR RESPONSE TO OXYGEN LEVELS 15 143 5.421e-06 3.368e-05
750 REGULATION OF PROTEIN CATABOLIC PROCESS 27 393 5.675e-06 3.516e-05
751 NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 14 126 5.673e-06 3.516e-05
752 MITOTIC CELL CYCLE 42 766 5.698e-06 3.525e-05
753 POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 10 64 5.951e-06 3.677e-05
754 RESPONSE TO COPPER ION 7 28 5.976e-06 3.683e-05
755 POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE 7 28 5.976e-06 3.683e-05
756 SECRETION 35 588 6.147e-06 3.783e-05
757 ARTERY MORPHOGENESIS 9 51 6.204e-06 3.813e-05
758 POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL 8 39 6.331e-06 3.876e-05
759 REGULATION OF GRANULOCYTE CHEMOTAXIS 8 39 6.331e-06 3.876e-05
760 POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 8 39 6.331e-06 3.876e-05
761 DETECTION OF OTHER ORGANISM 6 19 6.378e-06 3.895e-05
762 REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS 6 19 6.378e-06 3.895e-05
763 REGULATION OF RESPONSE TO OXIDATIVE STRESS 10 65 6.87e-06 4.189e-05
764 REGULATION OF MICROTUBULE BASED PROCESS 20 243 6.881e-06 4.191e-05
765 ACTIVATION OF MAPKK ACTIVITY 9 52 7.33e-06 4.458e-05
766 REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION 7 29 7.701e-06 4.678e-05
767 MAMMARY GLAND MORPHOGENESIS 8 40 7.734e-06 4.692e-05
768 NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION 12 96 7.811e-06 4.733e-05
769 CELL JUNCTION ORGANIZATION 17 185 7.913e-06 4.782e-05
770 REGULATION OF VASOCONSTRICTION 10 66 7.909e-06 4.782e-05
771 REGULATION OF EPITHELIAL CELL MIGRATION 16 166 7.95e-06 4.798e-05
772 RESPONSE TO TEMPERATURE STIMULUS 15 148 8.271e-06 4.985e-05
773 OVULATION CYCLE 13 113 8.318e-06 5.007e-05
774 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 9 53 8.626e-06 5.172e-05
775 MAMMARY GLAND EPITHELIUM DEVELOPMENT 9 53 8.626e-06 5.172e-05
776 MESONEPHRIC TUBULE MORPHOGENESIS 9 53 8.626e-06 5.172e-05
777 REGULATION OF INTERFERON GAMMA PRODUCTION 12 97 8.706e-06 5.213e-05
778 POSITIVE REGULATION OF CELL CYCLE PROCESS 20 247 8.776e-06 5.249e-05
779 ACTIN FILAMENT BASED PROCESS 29 450 8.845e-06 5.283e-05
780 NEGATIVE REGULATION OF BINDING 14 131 8.943e-06 5.335e-05
781 MACROMOLECULAR COMPLEX ASSEMBLY 64 1398 8.964e-06 5.341e-05
782 REGULATION OF ACTIN FILAMENT BASED PROCESS 23 312 9.008e-06 5.36e-05
783 REGULATION OF AXONOGENESIS 16 168 9.263e-06 5.504e-05
784 RECEPTOR METABOLIC PROCESS 11 82 9.382e-06 5.561e-05
785 INTEGRIN MEDIATED SIGNALING PATHWAY 11 82 9.382e-06 5.561e-05
786 B CELL ACTIVATION 14 132 9.768e-06 5.783e-05
787 NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 7 30 9.819e-06 5.783e-05
788 POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION 7 30 9.819e-06 5.783e-05
789 POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 7 30 9.819e-06 5.783e-05
790 OSTEOCLAST DIFFERENTIATION 7 30 9.819e-06 5.783e-05
791 LEUKOCYTE MEDIATED IMMUNITY 17 189 1.051e-05 6.183e-05
792 REGULATION OF LIPASE ACTIVITY 11 83 1.056e-05 6.206e-05
793 REGULATION OF CELL DIVISION 21 272 1.094e-05 6.413e-05
794 MULTICELLULAR ORGANISMAL HOMEOSTASIS 21 272 1.094e-05 6.413e-05
795 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 13 116 1.11e-05 6.489e-05
796 RESPONSE TO FIBROBLAST GROWTH FACTOR 13 116 1.11e-05 6.489e-05
797 LIPID MODIFICATION 18 210 1.133e-05 6.602e-05
798 NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 8 42 1.134e-05 6.602e-05
799 NEGATIVE REGULATION OF BMP SIGNALING PATHWAY 8 42 1.134e-05 6.602e-05
800 INTRINSIC APOPTOTIC SIGNALING PATHWAY 15 152 1.144e-05 6.653e-05
801 REGULATION OF BLOOD CIRCULATION 22 295 1.173e-05 6.817e-05
802 SINGLE ORGANISM CELLULAR LOCALIZATION 46 898 1.189e-05 6.896e-05
803 B CELL HOMEOSTASIS 6 21 1.22e-05 7.069e-05
804 TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER 15 153 1.238e-05 7.166e-05
805 REGULATION OF CELL SIZE 16 172 1.248e-05 7.214e-05
806 PROTEIN AUTOPHOSPHORYLATION 17 192 1.294e-05 7.468e-05
807 CARDIOBLAST DIFFERENTIATION 5 13 1.31e-05 7.533e-05
808 ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY 5 13 1.31e-05 7.533e-05
809 NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 5 13 1.31e-05 7.533e-05
810 POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY 11 85 1.332e-05 7.651e-05
811 MESODERM DEVELOPMENT 13 118 1.338e-05 7.678e-05
812 REGULATION OF CELL SUBSTRATE ADHESION 16 173 1.343e-05 7.694e-05
813 DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM 8 43 1.361e-05 7.79e-05
814 REGULATION OF CELL CYCLE PHASE TRANSITION 23 321 1.427e-05 8.154e-05
815 REGULATION OF PEPTIDE TRANSPORT 20 256 1.486e-05 8.485e-05
816 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 25 368 1.52e-05 8.666e-05
817 ENDODERM DEVELOPMENT 10 71 1.54e-05 8.769e-05
818 ENDOCARDIAL CUSHION DEVELOPMENT 7 32 1.551e-05 8.792e-05
819 PATTERNING OF BLOOD VESSELS 7 32 1.551e-05 8.792e-05
820 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 7 32 1.551e-05 8.792e-05
821 NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND 7 32 1.551e-05 8.792e-05
822 IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 23 323 1.576e-05 8.92e-05
823 REGULATION OF CIRCADIAN RHYTHM 12 103 1.62e-05 9.156e-05
824 CHROMATIN MODIFICATION 32 539 1.621e-05 9.156e-05
825 POSITIVE REGULATION OF MUSCLE CONTRACTION 8 44 1.626e-05 9.158e-05
826 NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 8 44 1.626e-05 9.158e-05
827 NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 6 22 1.64e-05 9.185e-05
828 REGULATION OF HAIR CYCLE 6 22 1.64e-05 9.185e-05
829 REGULATION OF INTERLEUKIN 17 PRODUCTION 6 22 1.64e-05 9.185e-05
830 REGULATION OF CELLULAR RESPIRATION 6 22 1.64e-05 9.185e-05
831 CELLULAR RESPONSE TO INTERLEUKIN 6 6 22 1.64e-05 9.185e-05
832 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 18 216 1.663e-05 9.302e-05
833 ENDOTHELIAL CELL DIFFERENTIATION 10 72 1.747e-05 9.745e-05
834 DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM 10 72 1.747e-05 9.745e-05
835 POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS 9 58 1.846e-05 0.0001028
836 MUSCLE SYSTEM PROCESS 21 282 1.888e-05 0.0001051
837 DENDRITIC CELL DIFFERENTIATION 7 33 1.925e-05 0.0001065
838 RESPONSE TO VITAMIN D 7 33 1.925e-05 0.0001065
839 NEGATIVE REGULATION OF JNK CASCADE 7 33 1.925e-05 0.0001065
840 RESPONSE TO DEXAMETHASONE 7 33 1.925e-05 0.0001065
841 REGULATION OF CELL AGING 7 33 1.925e-05 0.0001065
842 NEGATIVE REGULATION OF MAP KINASE ACTIVITY 10 73 1.977e-05 0.0001093
843 REGULATION OF PODOSOME ASSEMBLY 5 14 1.993e-05 0.0001096
844 CRANIOFACIAL SUTURE MORPHOGENESIS 5 14 1.993e-05 0.0001096
845 REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY 5 14 1.993e-05 0.0001096
846 POST EMBRYONIC ORGAN DEVELOPMENT 5 14 1.993e-05 0.0001096
847 REGULATION OF NUCLEASE ACTIVITY 6 23 2.17e-05 0.0001186
848 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 6 23 2.17e-05 0.0001186
849 INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 12 106 2.172e-05 0.0001186
850 REGULATION OF METANEPHROS DEVELOPMENT 6 23 2.17e-05 0.0001186
851 POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS 6 23 2.17e-05 0.0001186
852 NEUROTROPHIN SIGNALING PATHWAY 6 23 2.17e-05 0.0001186
853 ANATOMICAL STRUCTURE HOMEOSTASIS 21 285 2.21e-05 0.0001206
854 REGULATION OF ACUTE INFLAMMATORY RESPONSE 10 74 2.233e-05 0.0001215
855 REGULATION OF STEROID METABOLIC PROCESS 10 74 2.233e-05 0.0001215
856 EPIDERMAL CELL DIFFERENTIATION 14 142 2.253e-05 0.0001225
857 REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH 8 46 2.286e-05 0.000124
858 EMBRYONIC CRANIAL SKELETON MORPHOGENESIS 8 46 2.286e-05 0.000124
859 ENDOTHELIUM DEVELOPMENT 11 90 2.309e-05 0.0001251
860 RESPONSE TO FLUID SHEAR STRESS 7 34 2.37e-05 0.0001278
861 T CELL HOMEOSTASIS 7 34 2.37e-05 0.0001278
862 HEART VALVE DEVELOPMENT 7 34 2.37e-05 0.0001278
863 CELLULAR RESPONSE TO ALKALOID 7 34 2.37e-05 0.0001278
864 REGULATION OF MONOOXYGENASE ACTIVITY 9 60 2.446e-05 0.0001317
865 CHROMOSOME ORGANIZATION 49 1009 2.486e-05 0.0001337
866 DNA TEMPLATED TRANSCRIPTION INITIATION 17 202 2.503e-05 0.0001345
867 GRANULOCYTE MIGRATION 10 75 2.517e-05 0.0001349
868 CELLULAR GLUCOSE HOMEOSTASIS 10 75 2.517e-05 0.0001349
869 SEX DIFFERENTIATION 20 266 2.587e-05 0.0001385
870 NEGATIVE REGULATION OF PROTEIN SECRETION 12 108 2.625e-05 0.0001402
871 REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 12 108 2.625e-05 0.0001402
872 CARDIAC CHAMBER DEVELOPMENT 14 144 2.638e-05 0.0001408
873 REGULATION OF IMMUNOGLOBULIN PRODUCTION 8 47 2.692e-05 0.0001435
874 MONOCARBOXYLIC ACID METABOLIC PROCESS 30 503 2.733e-05 0.0001455
875 POSITIVE REGULATION OF STEM CELL PROLIFERATION 9 61 2.803e-05 0.0001491
876 POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION 6 24 2.83e-05 0.0001494
877 CELL SUBSTRATE ADHESION 15 164 2.832e-05 0.0001494
878 POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION 6 24 2.83e-05 0.0001494
879 POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 6 24 2.83e-05 0.0001494
880 NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION 6 24 2.83e-05 0.0001494
881 REGULATION OF ISOTYPE SWITCHING 6 24 2.83e-05 0.0001494
882 REGULATION OF ANOIKIS 6 24 2.83e-05 0.0001494
883 POSITIVE REGULATION OF VASOCONSTRICTION 7 35 2.895e-05 0.0001522
884 BONE REMODELING 7 35 2.895e-05 0.0001522
885 LIPID METABOLIC PROCESS 54 1158 2.891e-05 0.0001522
886 POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION 5 15 2.926e-05 0.0001525
887 REGULATION OF HAIR FOLLICLE DEVELOPMENT 5 15 2.926e-05 0.0001525
888 NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION 5 15 2.926e-05 0.0001525
889 NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION 5 15 2.926e-05 0.0001525
890 CHRONIC INFLAMMATORY RESPONSE 5 15 2.926e-05 0.0001525
891 POSITIVE REGULATION OF NUCLEASE ACTIVITY 5 15 2.926e-05 0.0001525
892 POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS 5 15 2.926e-05 0.0001525
893 T CELL APOPTOTIC PROCESS 5 15 2.926e-05 0.0001525
894 NEGATIVE REGULATION OF ION TRANSPORT 13 127 2.955e-05 0.0001538
895 REGULATION OF MYOBLAST DIFFERENTIATION 8 48 3.158e-05 0.000164
896 POSITIVE REGULATION OF WOUND HEALING 8 48 3.158e-05 0.000164
897 FOREBRAIN CELL MIGRATION 9 62 3.204e-05 0.000166
898 CARDIAC VENTRICLE MORPHOGENESIS 9 62 3.204e-05 0.000166
899 POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION 7 36 3.514e-05 0.0001817
900 DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE 7 36 3.514e-05 0.0001817
901 REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION 6 25 3.642e-05 0.0001881
902 REGULATION OF OSTEOCLAST DIFFERENTIATION 9 63 3.653e-05 0.0001882
903 RESPONSE TO OSMOTIC STRESS 9 63 3.653e-05 0.0001882
904 REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY 8 49 3.688e-05 0.0001898
905 COGNITION 19 251 3.736e-05 0.0001921
906 REGULATION OF VESICLE MEDIATED TRANSPORT 28 462 3.808e-05 0.0001956
907 NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 17 209 3.866e-05 0.0001983
908 NEGATIVE REGULATION OF PROTEIN BINDING 10 79 3.985e-05 0.0002042
909 CATABOLIC PROCESS 74 1773 4.063e-05 0.000208
910 RECEPTOR MEDIATED ENDOCYTOSIS 18 231 4.075e-05 0.0002083
911 REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS 5 16 4.164e-05 0.000212
912 REGULATION OF MONONUCLEAR CELL MIGRATION 5 16 4.164e-05 0.000212
913 APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS 5 16 4.164e-05 0.000212
914 REGULATION OF INTERLEUKIN 6 BIOSYNTHETIC PROCESS 5 16 4.164e-05 0.000212
915 NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION 7 37 4.237e-05 0.0002154
916 SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE 11 96 4.25e-05 0.0002159
917 PHAGOCYTOSIS 16 190 4.275e-05 0.0002169
918 CELLULAR RESPONSE TO CAMP 8 50 4.291e-05 0.0002175
919 REGULATION OF NUCLEOTIDE METABOLIC PROCESS 17 211 4.36e-05 0.0002208
920 FATTY ACID BIOSYNTHETIC PROCESS 12 114 4.512e-05 0.0002282
921 REGULATION OF CELLULAR SENESCENCE 6 26 4.63e-05 0.0002331
922 NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 6 26 4.63e-05 0.0002331
923 CELL CYCLE PHASE TRANSITION 19 255 4.633e-05 0.0002331
924 NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT 6 26 4.63e-05 0.0002331
925 RESPONSE TO INTERLEUKIN 6 6 26 4.63e-05 0.0002331
926 POSITIVE REGULATION OF WNT SIGNALING PATHWAY 14 152 4.815e-05 0.000242
927 MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS 15 172 4.933e-05 0.0002476
928 REGULATION OF JUN KINASE ACTIVITY 10 81 4.958e-05 0.0002486
929 POSITIVE REGULATION OF FAT CELL DIFFERENTIATION 8 51 4.974e-05 0.0002491
930 POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 7 38 5.077e-05 0.0002537
931 MESENCHYME MORPHOGENESIS 7 38 5.077e-05 0.0002537
932 MYELOID LEUKOCYTE ACTIVATION 11 98 5.152e-05 0.0002572
933 NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 9 66 5.329e-05 0.0002652
934 NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 9 66 5.329e-05 0.0002652
935 POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS 9 66 5.329e-05 0.0002652
936 RESPONSE TO LIGHT STIMULUS 20 280 5.344e-05 0.0002656
937 CELL CYCLE CHECKPOINT 16 194 5.496e-05 0.0002729
938 REGULATION OF PROTEIN MATURATION 10 82 5.517e-05 0.0002737
939 NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 5 17 5.773e-05 0.0002854
940 MEMBRANE RAFT ORGANIZATION 5 17 5.773e-05 0.0002854
941 REGULATION OF RECEPTOR BINDING 5 17 5.773e-05 0.0002854
942 SKELETAL MUSCLE TISSUE REGENERATION 6 27 5.822e-05 0.000287
943 POSITIVE REGULATION OF HEART GROWTH 6 27 5.822e-05 0.000287
944 AXIS ELONGATION 6 27 5.822e-05 0.000287
945 PEPTIDYL TYROSINE AUTOPHOSPHORYLATION 7 39 6.049e-05 0.0002975
946 PLATELET AGGREGATION 7 39 6.049e-05 0.0002975
947 NIK NF KAPPAB SIGNALING 10 83 6.128e-05 0.0003011
948 NEGATIVE REGULATION OF INFLAMMATORY RESPONSE 11 100 6.214e-05 0.0003047
949 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 11 100 6.214e-05 0.0003047
950 SMALL MOLECULE METABOLIC PROCESS 73 1767 6.39e-05 0.0003126
951 REGULATION OF LEUKOCYTE MEDIATED IMMUNITY 14 156 6.402e-05 0.0003126
952 PROTEIN LOCALIZATION TO NUCLEUS 14 156 6.402e-05 0.0003126
953 REGULATION OF TRANSMEMBRANE TRANSPORT 26 426 6.383e-05 0.0003126
954 POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 8 53 6.613e-05 0.0003225
955 REGULATION OF CELL JUNCTION ASSEMBLY 9 68 6.774e-05 0.0003293
956 REGULATION OF NEUROLOGICAL SYSTEM PROCESS 9 68 6.774e-05 0.0003293
957 POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION 9 68 6.774e-05 0.0003293
958 CAMERA TYPE EYE MORPHOGENESIS 11 101 6.811e-05 0.0003308
959 NEGATIVE REGULATION OF LOCOMOTION 19 263 7.021e-05 0.0003407
960 CELL CYCLE G2 M PHASE TRANSITION 13 138 7.061e-05 0.0003422
961 RESPONSE TO CADMIUM ION 7 40 7.168e-05 0.0003471
962 REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 6 28 7.247e-05 0.0003491
963 POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA 6 28 7.247e-05 0.0003491
964 REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION 6 28 7.247e-05 0.0003491
965 NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS 6 28 7.247e-05 0.0003491
966 MAMMARY GLAND DUCT MORPHOGENESIS 6 28 7.247e-05 0.0003491
967 CHROMATIN ORGANIZATION 35 663 7.442e-05 0.0003581
968 PALATE DEVELOPMENT 10 85 7.524e-05 0.0003617
969 NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION 9 69 7.612e-05 0.000364
970 REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS 8 54 7.587e-05 0.000364
971 POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY 9 69 7.612e-05 0.000364
972 MITOTIC CELL CYCLE CHECKPOINT 13 139 7.607e-05 0.000364
973 REGULATION OF CELL SHAPE 13 139 7.607e-05 0.000364
974 NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION 5 18 7.821e-05 0.0003714
975 SMOOTH MUSCLE TISSUE DEVELOPMENT 5 18 7.821e-05 0.0003714
976 CELLULAR LIPID METABOLIC PROCESS 44 913 7.78e-05 0.0003714
977 PHARYNGEAL SYSTEM DEVELOPMENT 5 18 7.821e-05 0.0003714
978 LYMPHOCYTE APOPTOTIC PROCESS 5 18 7.821e-05 0.0003714
979 MUSCLE CELL MIGRATION 5 18 7.821e-05 0.0003714
980 RESPONSE TO WATER 5 18 7.821e-05 0.0003714
981 NEGATIVE REGULATION OF IMMUNE RESPONSE 12 121 8.104e-05 0.0003844
982 POSITIVE REGULATION OF B CELL ACTIVATION 10 86 8.318e-05 0.0003941
983 NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY 7 41 8.451e-05 0.0003992
984 REGULATION OF B CELL MEDIATED IMMUNITY 7 41 8.451e-05 0.0003992
985 PROSTATE GLAND DEVELOPMENT 7 41 8.451e-05 0.0003992
986 I KAPPAB KINASE NF KAPPAB SIGNALING 9 70 8.535e-05 0.0004028
987 EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 8 55 8.677e-05 0.0004084
988 VIRAL LIFE CYCLE 20 290 8.68e-05 0.0004084
989 REGULATION OF MYOTUBE DIFFERENTIATION 8 55 8.677e-05 0.0004084
990 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 12 122 8.778e-05 0.0004126
991 REGULATION OF CELLULAR COMPONENT SIZE 22 337 8.795e-05 0.000413
992 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 11 104 8.908e-05 0.0004178
993 NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 6 29 8.936e-05 0.0004183
994 POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 6 29 8.936e-05 0.0004183
995 REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION 16 203 9.423e-05 0.0004406
996 REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 14 162 9.632e-05 0.00045
997 REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS 7 42 9.914e-05 0.0004622
998 EPITHELIAL CELL MORPHOGENESIS 7 42 9.914e-05 0.0004622
999 RAS PROTEIN SIGNAL TRANSDUCTION 13 143 0.0001017 0.0004738
1000 NEGATIVE REGULATION OF HOMEOSTATIC PROCESS 12 124 0.0001027 0.000478
1001 RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN 14 163 0.0001029 0.0004783
1002 VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION 5 19 0.0001039 0.0004785
1003 FIBRIL ORGANIZATION 5 19 0.0001039 0.0004785
1004 REGULATION OF WATER LOSS VIA SKIN 5 19 0.0001039 0.0004785
1005 MUSCLE CELL PROLIFERATION 5 19 0.0001039 0.0004785
1006 ORGANIC ACID METABOLIC PROCESS 45 953 0.0001032 0.0004785
1007 POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 5 19 0.0001039 0.0004785
1008 REGULATION OF INTERLEUKIN 8 SECRETION 5 19 0.0001039 0.0004785
1009 MACROPHAGE DIFFERENTIATION 5 19 0.0001039 0.0004785
1010 POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 5 19 0.0001039 0.0004785
1011 SEXUAL REPRODUCTION 37 730 0.0001071 0.0004931
1012 SMOOTH MUSCLE CELL DIFFERENTIATION 6 30 0.0001092 0.0005023
1013 REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY 10 89 0.0001114 0.0005116
1014 CELL FATE DETERMINATION 7 43 0.0001158 0.0005313
1015 SYNAPSE ORGANIZATION 13 145 0.0001172 0.0005371
1016 POSITIVE REGULATION OF PROTEIN BINDING 9 73 0.0001189 0.0005438
1017 PANCREAS DEVELOPMENT 9 73 0.0001189 0.0005438
1018 RESPONSE TO UV 12 126 0.0001198 0.0005477
1019 PATTERN SPECIFICATION PROCESS 25 418 0.0001209 0.0005521
1020 CALCIUM MEDIATED SIGNALING 10 90 0.0001224 0.0005573
1021 REGULATION OF CELL MATRIX ADHESION 10 90 0.0001224 0.0005573
1022 REGULATION OF GLIOGENESIS 10 90 0.0001224 0.0005573
1023 COVALENT CHROMATIN MODIFICATION 22 345 0.0001235 0.0005617
1024 CELLULAR RESPONSE TO INSULIN STIMULUS 13 146 0.0001256 0.0005696
1025 NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION 13 146 0.0001256 0.0005696
1026 DNA INTEGRITY CHECKPOINT 13 146 0.0001256 0.0005696
1027 REGULATION OF MULTI ORGANISM PROCESS 27 470 0.0001276 0.0005781
1028 RESPONSE TO INTERLEUKIN 4 6 31 0.0001325 0.0005958
1029 POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 4 11 0.0001328 0.0005958
1030 REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION 6 31 0.0001325 0.0005958
1031 CARDIAC CELL FATE COMMITMENT 4 11 0.0001328 0.0005958
1032 DETECTION OF MOLECULE OF BACTERIAL ORIGIN 4 11 0.0001328 0.0005958
1033 POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS 4 11 0.0001328 0.0005958
1034 REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION 6 31 0.0001325 0.0005958
1035 LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE 4 11 0.0001328 0.0005958
1036 NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION 4 11 0.0001328 0.0005958
1037 REGULATION OF NECROPTOTIC PROCESS 4 11 0.0001328 0.0005958
1038 REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 13 147 0.0001346 0.0006028
1039 REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA 7 44 0.0001346 0.0006028
1040 RESPONSE TO PROTOZOAN 5 20 0.0001355 0.0006046
1041 RESPONSE TO LIPOPROTEIN PARTICLE 5 20 0.0001355 0.0006046
1042 NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 5 20 0.0001355 0.0006046
1043 MYELOID DENDRITIC CELL DIFFERENTIATION 5 20 0.0001355 0.0006046
1044 NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS 11 109 0.0001363 0.0006069
1045 UNSATURATED FATTY ACID METABOLIC PROCESS 11 109 0.0001363 0.0006069
1046 NEGATIVE REGULATION OF HEMOPOIESIS 12 128 0.0001393 0.000619
1047 MUSCLE CELL DEVELOPMENT 12 128 0.0001393 0.000619
1048 POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION 26 448 0.0001441 0.000639
1049 POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 8 59 0.0001442 0.000639
1050 VASCULOGENESIS 8 59 0.0001442 0.000639
1051 REGULATION OF CHROMOSOME ORGANIZATION 19 278 0.0001456 0.0006447
1052 MITOCHONDRIAL MEMBRANE ORGANIZATION 10 92 0.0001473 0.0006514
1053 CELL PART MORPHOGENESIS 33 633 0.0001503 0.0006643
1054 CELLULAR MACROMOLECULE LOCALIZATION 54 1234 0.0001522 0.0006721
1055 THYMOCYTE AGGREGATION 7 45 0.0001558 0.0006834
1056 SPROUTING ANGIOGENESIS 7 45 0.0001558 0.0006834
1057 REGULATION OF EPIDERMAL CELL DIFFERENTIATION 7 45 0.0001558 0.0006834
1058 T CELL DIFFERENTIATION IN THYMUS 7 45 0.0001558 0.0006834
1059 HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES 7 45 0.0001558 0.0006834
1060 NEGATIVE REGULATION OF CHROMATIN MODIFICATION 7 45 0.0001558 0.0006834
1061 ENDOCHONDRAL BONE MORPHOGENESIS 7 45 0.0001558 0.0006834
1062 POSITIVE REGULATION OF DENDRITE MORPHOGENESIS 6 32 0.0001595 0.0006981
1063 ADIPOSE TISSUE DEVELOPMENT 6 32 0.0001595 0.0006981
1064 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 10 93 0.0001612 0.000705
1065 REGULATION OF CALCIUM MEDIATED SIGNALING 9 76 0.0001628 0.0007097
1066 GLIAL CELL DEVELOPMENT 9 76 0.0001628 0.0007097
1067 OLIGODENDROCYTE DIFFERENTIATION 8 60 0.0001626 0.0007097
1068 REGULATION OF HORMONE LEVELS 27 478 0.0001679 0.0007315
1069 TISSUE HOMEOSTASIS 14 171 0.0001711 0.0007445
1070 POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT 12 131 0.0001735 0.0007546
1071 CELL AGGREGATION 5 21 0.0001741 0.0007548
1072 APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT 5 21 0.0001741 0.0007548
1073 CARTILAGE CONDENSATION 5 21 0.0001741 0.0007548
1074 REGULATION OF CELLULAR AMIDE METABOLIC PROCESS 22 354 0.0001782 0.0007722
1075 PEPTIDYL THREONINE MODIFICATION 7 46 0.0001797 0.0007778
1076 REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY 8 61 0.0001829 0.0007911
1077 REGULATION OF CHROMATIN ORGANIZATION 13 152 0.0001881 0.0008126
1078 POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION 6 33 0.0001907 0.0008206
1079 SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND 6 33 0.0001907 0.0008206
1080 EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 6 33 0.0001907 0.0008206
1081 REGULATION OF INTERLEUKIN 1 SECRETION 6 33 0.0001907 0.0008206
1082 POSITIVE REGULATION OF CELLULAR EXTRAVASATION 4 12 0.000195 0.0008341
1083 REGULATION OF MACROPHAGE CYTOKINE PRODUCTION 4 12 0.000195 0.0008341
1084 POSITIVE REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS 4 12 0.000195 0.0008341
1085 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 4 12 0.000195 0.0008341
1086 POSITIVE REGULATION OF CATENIN IMPORT INTO NUCLEUS 4 12 0.000195 0.0008341
1087 NEGATIVE REGULATION OF RECEPTOR BINDING 4 12 0.000195 0.0008341
1088 POSITIVE REGULATION OF CAMP MEDIATED SIGNALING 4 12 0.000195 0.0008341
1089 LYMPHOCYTE COSTIMULATION 9 78 0.0001989 0.00085
1090 POSITIVE REGULATION OF PURINE NUCLEOTIDE METABOLIC PROCESS 12 133 0.0002002 0.0008537
1091 POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS 12 133 0.0002002 0.0008537
1092 ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY 15 195 0.000202 0.0008609
1093 REGULATION OF HORMONE SECRETION 18 262 0.0002026 0.0008627
1094 NOTCH SIGNALING PATHWAY 11 114 0.0002033 0.0008646
1095 REGULATION OF TISSUE REMODELING 8 62 0.0002053 0.0008724
1096 POSITIVE REGULATION OF GLIOGENESIS 7 47 0.0002064 0.0008764
1097 PROTEIN LOCALIZATION 72 1805 0.0002099 0.0008895
1098 REACTIVE OXYGEN SPECIES METABOLIC PROCESS 10 96 0.0002099 0.0008895
1099 POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL 15 196 0.0002136 0.0009045
1100 REGULATION OF MITOCHONDRION ORGANIZATION 16 218 0.000215 0.0009094
1101 PROTEIN OLIGOMERIZATION 25 434 0.0002157 0.0009116
1102 CELL DIVISION 26 460 0.0002185 0.0009224
1103 SECRETION BY CELL 27 486 0.0002192 0.0009246
1104 ERBB SIGNALING PATHWAY 9 79 0.0002194 0.0009246
1105 CELLULAR RESPONSE TO VIRUS 5 22 0.0002204 0.0009265
1106 ENDOCARDIAL CUSHION MORPHOGENESIS 5 22 0.0002204 0.0009265
1107 POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT 5 22 0.0002204 0.0009265
1108 REGULATION OF CELL KILLING 8 63 0.0002298 0.0009652
1109 PEPTIDYL LYSINE MODIFICATION 20 312 0.0002314 0.000971
1110 RESPONSE TO AMINE 7 48 0.0002363 0.0009887
1111 REGULATION OF NF KAPPAB IMPORT INTO NUCLEUS 7 48 0.0002363 0.0009887
1112 REGULATION OF INTERLEUKIN 2 PRODUCTION 7 48 0.0002363 0.0009887
1113 NEGATIVE REGULATION OF LIPID METABOLIC PROCESS 9 80 0.0002415 0.00101
1114 HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION 10 98 0.0002488 0.001039
1115 POSITIVE REGULATION OF DENDRITE DEVELOPMENT 8 64 0.0002567 0.00107
1116 POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS 8 64 0.0002567 0.00107
1117 REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION 14 178 0.0002597 0.001082
1118 CELLULAR RESPONSE TO RADIATION 12 137 0.000264 0.001099
1119 NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS 6 35 0.0002673 0.001106
1120 NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION 6 35 0.0002673 0.001106
1121 POSITIVE REGULATION OF HEART CONTRACTION 6 35 0.0002673 0.001106
1122 NEGATIVE REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS 6 35 0.0002673 0.001106
1123 RESPONSE TO IRON ION 6 35 0.0002673 0.001106
1124 B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 6 35 0.0002673 0.001106
1125 ACTIN FILAMENT BUNDLE ORGANIZATION 7 49 0.0002695 0.001113
1126 CARDIAC SEPTUM MORPHOGENESIS 7 49 0.0002695 0.001113
1127 CARDIAC CELL DEVELOPMENT 7 49 0.0002695 0.001113
1128 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 10 99 0.0002704 0.001114
1129 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 10 99 0.0002704 0.001114
1130 CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS 4 13 0.0002759 0.001116
1131 PROSTATE GLAND MORPHOGENESIS 5 23 0.0002756 0.001116
1132 WHITE FAT CELL DIFFERENTIATION 4 13 0.0002759 0.001116
1133 POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 5 23 0.0002756 0.001116
1134 PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 4 13 0.0002759 0.001116
1135 REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE 4 13 0.0002759 0.001116
1136 POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS 4 13 0.0002759 0.001116
1137 HORMONE MEDIATED SIGNALING PATHWAY 13 158 0.0002756 0.001116
1138 EYELID DEVELOPMENT IN CAMERA TYPE EYE 4 13 0.0002759 0.001116
1139 REGULATION OF CAMP MEDIATED SIGNALING 5 23 0.0002756 0.001116
1140 REGULATION OF REGULATORY T CELL DIFFERENTIATION 4 13 0.0002759 0.001116
1141 RESPONSE TO AUDITORY STIMULUS 5 23 0.0002756 0.001116
1142 TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY 11 118 0.0002753 0.001116
1143 POSITIVE REGULATION OF NEUROLOGICAL SYSTEM PROCESS 5 23 0.0002756 0.001116
1144 RESPONSE TO PARATHYROID HORMONE 4 13 0.0002759 0.001116
1145 NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY 4 13 0.0002759 0.001116
1146 RESPONSE TO COBALT ION 4 13 0.0002759 0.001116
1147 REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS 4 13 0.0002759 0.001116
1148 VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT 4 13 0.0002759 0.001116
1149 POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 4 13 0.0002759 0.001116
1150 REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY 4 13 0.0002759 0.001116
1151 MAINTENANCE OF LOCATION 12 138 0.0002824 0.001142
1152 NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 9 82 0.0002915 0.001177
1153 METENCEPHALON DEVELOPMENT 10 100 0.0002935 0.001183
1154 MITOTIC DNA INTEGRITY CHECKPOINT 10 100 0.0002935 0.001183
1155 CELL MATRIX ADHESION 11 119 0.0002963 0.001193
1156 POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 11 119 0.0002963 0.001193
1157 POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 7 50 0.0003064 0.001232
1158 SECOND MESSENGER MEDIATED SIGNALING 13 160 0.0003116 0.001252
1159 NEUROMUSCULAR JUNCTION DEVELOPMENT 6 36 0.0003137 0.001256
1160 NEGATIVE REGULATION OF HISTONE MODIFICATION 6 36 0.0003137 0.001256
1161 NEGATIVE REGULATION OF BLOOD CIRCULATION 6 36 0.0003137 0.001256
1162 CELLULAR RESPONSE TO HEAT 6 36 0.0003137 0.001256
1163 REGULATION OF MULTICELLULAR ORGANISM GROWTH 8 66 0.0003183 0.001271
1164 KERATINOCYTE DIFFERENTIATION 10 101 0.0003183 0.001271
1165 REGULATION OF EXTENT OF CELL GROWTH 10 101 0.0003183 0.001271
1166 REGULATION OF DENDRITE DEVELOPMENT 11 120 0.0003186 0.001272
1167 NEGATIVE REGULATION OF STEROID METABOLIC PROCESS 5 24 0.0003407 0.001356
1168 POSITIVE REGULATION OF INTERLEUKIN 1 SECRETION 5 24 0.0003407 0.001356
1169 REGULATION OF ODONTOGENESIS 5 24 0.0003407 0.001356
1170 NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS 10 102 0.0003448 0.001371
1171 RESPONSE TO AMMONIUM ION 7 51 0.0003473 0.001374
1172 POSITIVE REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 7 51 0.0003473 0.001374
1173 REGULATION OF SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM 15 205 0.0003466 0.001374
1174 CELLULAR RESPONSE TO FATTY ACID 7 51 0.0003473 0.001374
1175 HOMOTYPIC CELL CELL ADHESION 7 51 0.0003473 0.001374
1176 POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION 7 51 0.0003473 0.001374
1177 NEURON FATE COMMITMENT 8 67 0.0003533 0.001397
1178 REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 14 184 0.0003646 0.00144
1179 RESPONSE TO NERVE GROWTH FACTOR 6 37 0.0003662 0.001442
1180 POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY 6 37 0.0003662 0.001442
1181 REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 6 37 0.0003662 0.001442
1182 POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION 6 37 0.0003662 0.001442
1183 LOCALIZATION WITHIN MEMBRANE 11 122 0.0003676 0.001446
1184 POSITIVE REGULATION OF METANEPHROS DEVELOPMENT 4 14 0.0003783 0.001477
1185 LAYER FORMATION IN CEREBRAL CORTEX 4 14 0.0003783 0.001477
1186 NEGATIVE REGULATION OF JUN KINASE ACTIVITY 4 14 0.0003783 0.001477
1187 ATRIAL SEPTUM MORPHOGENESIS 4 14 0.0003783 0.001477
1188 POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE 4 14 0.0003783 0.001477
1189 RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE 4 14 0.0003783 0.001477
1190 METANEPHRIC MESENCHYME DEVELOPMENT 4 14 0.0003783 0.001477
1191 POSITIVE REGULATION OF SPROUTING ANGIOGENESIS 4 14 0.0003783 0.001477
1192 REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 4 14 0.0003783 0.001477
1193 NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE 7 52 0.0003923 0.001523
1194 REGULATION OF ALPHA BETA T CELL ACTIVATION 8 68 0.0003914 0.001523
1195 NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS 7 52 0.0003923 0.001523
1196 NEGATIVE REGULATION OF T CELL PROLIFERATION 7 52 0.0003923 0.001523
1197 POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY 7 52 0.0003923 0.001523
1198 RESPONSE TO FUNGUS 7 52 0.0003923 0.001523
1199 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 8 68 0.0003914 0.001523
1200 LENS FIBER CELL DIFFERENTIATION 5 25 0.0004168 0.001609
1201 MEMBRANE ASSEMBLY 5 25 0.0004168 0.001609
1202 CELLULAR EXTRAVASATION 5 25 0.0004168 0.001609
1203 HISTONE PHOSPHORYLATION 5 25 0.0004168 0.001609
1204 POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 5 25 0.0004168 0.001609
1205 THYROID GLAND DEVELOPMENT 5 25 0.0004168 0.001609
1206 NEGATIVE REGULATION OF DEFENSE RESPONSE 12 144 0.0004174 0.00161
1207 SINGLE ORGANISM CATABOLIC PROCESS 43 957 0.0004229 0.00163
1208 POSITIVE REGULATION OF ORGAN GROWTH 6 38 0.0004254 0.001639
1209 RESPONSE TO ACTIVITY 8 69 0.0004327 0.001665
1210 NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT 9 87 0.0004546 0.001748
1211 CARDIAC VENTRICLE DEVELOPMENT 10 106 0.0004698 0.001805
1212 POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION 13 167 0.0004709 0.001808
1213 T CELL RECEPTOR SIGNALING PATHWAY 12 146 0.0004731 0.001815
1214 REGULATION OF MEMBRANE PERMEABILITY 8 70 0.0004775 0.00183
1215 REGULATION OF PHOSPHOLIPASE C ACTIVITY 6 39 0.0004917 0.001879
1216 TRABECULA MORPHOGENESIS 6 39 0.0004917 0.001879
1217 CELLULAR RESPONSE TO NUTRIENT 6 39 0.0004917 0.001879
1218 SPLEEN DEVELOPMENT 6 39 0.0004917 0.001879
1219 OVULATION CYCLE PROCESS 9 88 0.0004949 0.001889
1220 REGULATION OF TYPE 2 IMMUNE RESPONSE 5 26 0.000505 0.001899
1221 POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY 5 26 0.000505 0.001899
1222 RESPONSE TO MURAMYL DIPEPTIDE 4 15 0.0005052 0.001899
1223 REGULATION OF MESONEPHROS DEVELOPMENT 5 26 0.000505 0.001899
1224 NEGATIVE REGULATION OF HISTONE ACETYLATION 4 15 0.0005052 0.001899
1225 REPLACEMENT OSSIFICATION 5 26 0.000505 0.001899
1226 CELLULAR RESPONSE TO INTERLEUKIN 4 5 26 0.000505 0.001899
1227 POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS 4 15 0.0005052 0.001899
1228 LYMPHOCYTE MEDIATED IMMUNITY 12 147 0.0005032 0.001899
1229 NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY 5 26 0.000505 0.001899
1230 JAK STAT CASCADE INVOLVED IN GROWTH HORMONE SIGNALING PATHWAY 4 15 0.0005052 0.001899
1231 POSITIVE REGULATION OF IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE 5 26 0.000505 0.001899
1232 MESODERMAL CELL DIFFERENTIATION 5 26 0.000505 0.001899
1233 MUSCLE CELL FATE COMMITMENT 4 15 0.0005052 0.001899
1234 STRIATED MUSCLE CELL PROLIFERATION 4 15 0.0005052 0.001899
1235 RESPONSE TO HYDROPEROXIDE 4 15 0.0005052 0.001899
1236 ENDOCHONDRAL OSSIFICATION 5 26 0.000505 0.001899
1237 CELLULAR RESPONSE TO VITAMIN 5 26 0.000505 0.001899
1238 MYELOID DENDRITIC CELL ACTIVATION 5 26 0.000505 0.001899
1239 PLATELET DEGRANULATION 10 107 0.0005064 0.001902
1240 GAMETE GENERATION 30 595 0.0005177 0.001943
1241 SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 11 127 0.0005185 0.001944
1242 REGULATION OF BLOOD PRESSURE 13 169 0.0005274 0.001973
1243 APPENDAGE DEVELOPMENT 13 169 0.0005274 0.001973
1244 LIMB DEVELOPMENT 13 169 0.0005274 0.001973
1245 MALE SEX DIFFERENTIATION 12 148 0.0005348 0.001999
1246 POSITIVE REGULATION OF CAMP METABOLIC PROCESS 9 89 0.0005381 0.002009
1247 NEGATIVE REGULATION OF CELL CYCLE PROCESS 15 214 0.0005452 0.002034
1248 REGULATION OF PHOSPHATASE ACTIVITY 11 128 0.0005541 0.002066
1249 NAD METABOLIC PROCESS 7 55 0.0005563 0.002071
1250 NATURAL KILLER CELL ACTIVATION 7 55 0.0005563 0.002071
1251 NEGATIVE REGULATION OF CELL GROWTH 13 170 0.0005578 0.002075
1252 HINDBRAIN MORPHOGENESIS 6 40 0.0005659 0.002101
1253 NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION 6 40 0.0005659 0.002101
1254 PHOSPHATIDYLINOSITOL METABOLIC PROCESS 14 193 0.000589 0.002185
1255 REGIONALIZATION 19 311 0.0005944 0.002204
1256 ORGANOPHOSPHATE METABOLIC PROCESS 40 885 0.000597 0.002212
1257 NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 5 27 0.0006065 0.002235
1258 POSITIVE REGULATION OF NEUTROPHIL MIGRATION 5 27 0.0006065 0.002235
1259 POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION 5 27 0.0006065 0.002235
1260 NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 5 27 0.0006065 0.002235
1261 CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS 5 27 0.0006065 0.002235
1262 POSITIVE REGULATION OF NF KAPPAB IMPORT INTO NUCLEUS 5 27 0.0006065 0.002235
1263 HETEROTYPIC CELL CELL ADHESION 5 27 0.0006065 0.002235
1264 REGULATION OF CARBOHYDRATE METABOLIC PROCESS 13 172 0.0006229 0.002293
1265 NEURON MIGRATION 10 110 0.0006304 0.002319
1266 HIPPOCAMPUS DEVELOPMENT 8 73 0.000635 0.002334
1267 REGULATION OF LIPID STORAGE 6 41 0.0006484 0.002376
1268 TRANSLESION SYNTHESIS 6 41 0.0006484 0.002376
1269 CELLULAR RESPONSE TO ESTROGEN STIMULUS 6 41 0.0006484 0.002376
1270 MONOCYTE CHEMOTAXIS 6 41 0.0006484 0.002376
1271 MODULATION OF GROWTH OF SYMBIONT INVOLVED IN INTERACTION WITH HOST 4 16 0.0006598 0.002406
1272 CARDIAC MYOFIBRIL ASSEMBLY 4 16 0.0006598 0.002406
1273 REGULATION OF MACROPHAGE CHEMOTAXIS 4 16 0.0006598 0.002406
1274 CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT 4 16 0.0006598 0.002406
1275 NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 4 16 0.0006598 0.002406
1276 MONOCYTE DIFFERENTIATION 4 16 0.0006598 0.002406
1277 LEARNING 11 131 0.0006735 0.002454
1278 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 10 111 0.0006769 0.002465
1279 SMALL MOLECULE BIOSYNTHETIC PROCESS 24 443 0.0006887 0.002505
1280 POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION 7 57 0.0006929 0.002517
1281 APOPTOTIC MITOCHONDRIAL CHANGES 7 57 0.0006929 0.002517
1282 ACTIN FILAMENT ORGANIZATION 13 174 0.0006944 0.00252
1283 REGULATION OF DENDRITE MORPHOGENESIS 8 74 0.000696 0.002524
1284 POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 5 28 0.0007226 0.002603
1285 NECROTIC CELL DEATH 5 28 0.0007226 0.002603
1286 CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER 5 28 0.0007226 0.002603
1287 REGULATION OF NEUROBLAST PROLIFERATION 5 28 0.0007226 0.002603
1288 LONG TERM MEMORY 5 28 0.0007226 0.002603
1289 T CELL MEDIATED IMMUNITY 5 28 0.0007226 0.002603
1290 REGULATION OF SPROUTING ANGIOGENESIS 5 28 0.0007226 0.002603
1291 RESPONSE TO GONADOTROPIN 5 28 0.0007226 0.002603
1292 POSITIVE REGULATION OF PHOSPHATASE ACTIVITY 5 28 0.0007226 0.002603
1293 POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 6 42 0.0007399 0.002661
1294 REGULATION OF NIK NF KAPPAB SIGNALING 6 42 0.0007399 0.002661
1295 REGULATION OF DNA REPAIR 8 75 0.0007616 0.002734
1296 ODONTOGENESIS OF DENTIN CONTAINING TOOTH 8 75 0.0007616 0.002734
1297 REGULATION OF DNA RECOMBINATION 7 58 0.0007705 0.002764
1298 CARBOXYLIC ACID BIOSYNTHETIC PROCESS 17 270 0.0008139 0.002913
1299 MORPHOGENESIS OF EMBRYONIC EPITHELIUM 11 134 0.0008137 0.002913
1300 ORGANIC ACID BIOSYNTHETIC PROCESS 17 270 0.0008139 0.002913
1301 REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY 10 114 0.0008338 0.00298
1302 REGULATION OF EMBRYONIC DEVELOPMENT 10 114 0.0008338 0.00298
1303 NEGATIVE REGULATION OF KIDNEY DEVELOPMENT 4 17 0.000845 0.00299
1304 BRANCH ELONGATION OF AN EPITHELIUM 4 17 0.000845 0.00299
1305 POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER 4 17 0.000845 0.00299
1306 HEXOSE TRANSMEMBRANE TRANSPORT 4 17 0.000845 0.00299
1307 ANATOMICAL STRUCTURE ARRANGEMENT 4 17 0.000845 0.00299
1308 NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 6 43 0.0008411 0.00299
1309 NEGATIVE REGULATION OF CELL AGING 4 17 0.000845 0.00299
1310 REGULATION OF PLATELET AGGREGATION 4 17 0.000845 0.00299
1311 POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION 4 17 0.000845 0.00299
1312 MORPHOGENESIS OF AN EPITHELIAL SHEET 6 43 0.0008411 0.00299
1313 POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN 4 17 0.000845 0.00299
1314 GLUCOSE TRANSMEMBRANE TRANSPORT 4 17 0.000845 0.00299
1315 REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 4 17 0.000845 0.00299
1316 REGULATION OF CELL CYCLE G2 M PHASE TRANSITION 7 59 0.0008548 0.003013
1317 STEM CELL DIVISION 5 29 0.0008546 0.003013
1318 POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING 5 29 0.0008546 0.003013
1319 REGULATION OF THE FORCE OF HEART CONTRACTION 5 29 0.0008546 0.003013
1320 MUSCLE ADAPTATION 5 29 0.0008546 0.003013
1321 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 11 135 0.0008654 0.003046
1322 FATTY ACID METABOLIC PROCESS 18 296 0.0008653 0.003046
1323 REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 9 95 0.0008664 0.003047
1324 DNA METABOLIC PROCESS 35 758 0.000898 0.003156
1325 NEGATIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 11 136 0.0009199 0.00323
1326 T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 7 60 0.0009462 0.003318
1327 MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY 7 60 0.0009462 0.003318
1328 FEMALE SEX DIFFERENTIATION 10 116 0.0009541 0.003343
1329 REGULATION OF DEPHOSPHORYLATION 12 158 0.0009549 0.003343
1330 HINDBRAIN DEVELOPMENT 11 137 0.0009771 0.003418
1331 POSITIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION 5 30 0.001004 0.003493
1332 MEMBRANE BIOGENESIS 5 30 0.001004 0.003493
1333 POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 5 30 0.001004 0.003493
1334 BLASTOCYST FORMATION 5 30 0.001004 0.003493
1335 BROWN FAT CELL DIFFERENTIATION 5 30 0.001004 0.003493
1336 RESPONSE TO ATP 5 30 0.001004 0.003493
1337 CELLULAR RESPONSE TO ESTRADIOL STIMULUS 5 30 0.001004 0.003493
1338 WNT SIGNALING PATHWAY 20 351 0.001025 0.003565
1339 NEGATIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT 7 61 0.001045 0.003632
1340 ATRIAL SEPTUM DEVELOPMENT 4 18 0.001064 0.003687
1341 RESPONSE TO CAFFEINE 4 18 0.001064 0.003687
1342 KIDNEY MESENCHYME DEVELOPMENT 4 18 0.001064 0.003687
1343 POSITIVE REGULATION OF DNA RECOMBINATION 4 18 0.001064 0.003687
1344 ENDOTHELIAL CELL DEVELOPMENT 6 45 0.001075 0.003717
1345 POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION 6 45 0.001075 0.003717
1346 SMOOTH MUSCLE CONTRACTION 6 45 0.001075 0.003717
1347 MEMORY 9 98 0.001083 0.003739
1348 NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 9 98 0.001083 0.003739
1349 NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL 11 139 0.001101 0.003796
1350 FC RECEPTOR SIGNALING PATHWAY 14 206 0.001113 0.003835
1351 BLASTOCYST DEVELOPMENT 7 62 0.001152 0.003968
1352 GLUCOSE METABOLIC PROCESS 10 119 0.001161 0.003996
1353 DNA DEPENDENT DNA REPLICATION 9 99 0.001164 0.004001
1354 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 9 99 0.001164 0.004001
1355 CARDIAC ATRIUM DEVELOPMENT 5 31 0.001171 0.004007
1356 REGULATION OF MICROTUBULE POLYMERIZATION 5 31 0.001171 0.004007
1357 NEURON FATE SPECIFICATION 5 31 0.001171 0.004007
1358 POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION 5 31 0.001171 0.004007
1359 MISMATCH REPAIR 5 31 0.001171 0.004007
1360 REGULATION OF PLATELET ACTIVATION 5 31 0.001171 0.004007
1361 ICOSANOID BIOSYNTHETIC PROCESS 6 46 0.00121 0.004126
1362 CEREBELLAR CORTEX DEVELOPMENT 6 46 0.00121 0.004126
1363 REGULATION OF ALPHA BETA T CELL DIFFERENTIATION 6 46 0.00121 0.004126
1364 FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS 6 46 0.00121 0.004126
1365 DNA REPLICATION 14 208 0.001221 0.004161
1366 NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS 7 63 0.001267 0.004317
1367 REGULATION OF PEPTIDE SECRETION 14 209 0.001278 0.004349
1368 PROSTAGLANDIN BIOSYNTHETIC PROCESS 4 19 0.00132 0.004448
1369 NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION 4 19 0.00132 0.004448
1370 THYMIC T CELL SELECTION 4 19 0.00132 0.004448
1371 CELLULAR RESPONSE TO FLUID SHEAR STRESS 4 19 0.00132 0.004448
1372 DEFENSE RESPONSE TO VIRUS 12 164 0.001319 0.004448
1373 REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 4 19 0.00132 0.004448
1374 NEGATIVE REGULATION OF NUCLEOSIDE METABOLIC PROCESS 4 19 0.00132 0.004448
1375 NEGATIVE REGULATION OF ATP METABOLIC PROCESS 4 19 0.00132 0.004448
1376 ENTEROENDOCRINE CELL DIFFERENTIATION 4 19 0.00132 0.004448
1377 CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS 4 19 0.00132 0.004448
1378 ERROR PRONE TRANSLESION SYNTHESIS 4 19 0.00132 0.004448
1379 MUSCLE CELL CELLULAR HOMEOSTASIS 4 19 0.00132 0.004448
1380 PROSTANOID BIOSYNTHETIC PROCESS 4 19 0.00132 0.004448
1381 ASTROCYTE DEVELOPMENT 4 19 0.00132 0.004448
1382 MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY 5 32 0.001359 0.004557
1383 BLOOD VESSEL REMODELING 5 32 0.001359 0.004557
1384 NEGATIVE REGULATION OF T CELL DIFFERENTIATION 5 32 0.001359 0.004557
1385 NEURON DEATH 6 47 0.001356 0.004557
1386 POSITIVE REGULATION OF DEPHOSPHORYLATION 6 47 0.001356 0.004557
1387 REGULATION OF NEUTROPHIL MIGRATION 5 32 0.001359 0.004557
1388 NEGATIVE REGULATION OF TRANSPORTER ACTIVITY 7 64 0.001391 0.004661
1389 REGULATION OF PROTEIN ACETYLATION 7 64 0.001391 0.004661
1390 MICROTUBULE BASED PROCESS 26 522 0.001422 0.004761
1391 MITOTIC NUCLEAR DIVISION 20 361 0.001437 0.004806
1392 OXIDATION REDUCTION PROCESS 39 898 0.001455 0.004862
1393 ESTABLISHMENT OF LOCALIZATION IN CELL 64 1676 0.001464 0.00489
1394 RESPONSE TO FATTY ACID 8 83 0.001485 0.004955
1395 RESPONSE TO AXON INJURY 6 48 0.001516 0.005044
1396 NEGATIVE REGULATION OF COAGULATION 6 48 0.001516 0.005044
1397 REGULATION OF LIPID KINASE ACTIVITY 6 48 0.001516 0.005044
1398 DIGESTIVE TRACT MORPHOGENESIS 6 48 0.001516 0.005044
1399 COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT 6 48 0.001516 0.005044
1400 PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 7 65 0.001525 0.005068
1401 ANTIGEN PROCESSING AND PRESENTATION 14 213 0.001529 0.005077
1402 POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS 5 33 0.001567 0.005193
1403 EMBRYONIC EYE MORPHOGENESIS 5 33 0.001567 0.005193
1404 G2 DNA DAMAGE CHECKPOINT 5 33 0.001567 0.005193
1405 CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION 4 20 0.001616 0.005311
1406 NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 4 20 0.001616 0.005311
1407 NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY 4 20 0.001616 0.005311
1408 ESTABLISHMENT OF MITOTIC SPINDLE ORIENTATION 4 20 0.001616 0.005311
1409 NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 8 84 0.001604 0.005311
1410 CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS 4 20 0.001616 0.005311
1411 TELENCEPHALON GLIAL CELL MIGRATION 4 20 0.001616 0.005311
1412 ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS 4 20 0.001616 0.005311
1413 MEGAKARYOCYTE DIFFERENTIATION 4 20 0.001616 0.005311
1414 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT5 PROTEIN 4 20 0.001616 0.005311
1415 BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS 4 20 0.001616 0.005311
1416 RESPONSE TO LEAD ION 4 20 0.001616 0.005311
1417 CELLULAR RESPONSE TO UV 7 66 0.001668 0.005473
1418 LENS DEVELOPMENT IN CAMERA TYPE EYE 7 66 0.001668 0.005473
1419 STEROID HORMONE MEDIATED SIGNALING PATHWAY 10 125 0.001685 0.005524
1420 REGULATION OF NUCLEOSIDE METABOLIC PROCESS 6 49 0.00169 0.005535
1421 REGULATION OF ATP METABOLIC PROCESS 6 49 0.00169 0.005535
1422 CARDIAC SEPTUM DEVELOPMENT 8 85 0.001731 0.005664
1423 PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 5 34 0.001798 0.005868
1424 CD4 POSITIVE ALPHA BETA T CELL ACTIVATION 5 34 0.001798 0.005868
1425 ER NUCLEUS SIGNALING PATHWAY 5 34 0.001798 0.005868
1426 REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 5 34 0.001798 0.005868
1427 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 7 67 0.001821 0.00593
1428 REGULATION OF NOTCH SIGNALING PATHWAY 7 67 0.001821 0.00593
1429 REGULATION OF PROTEIN COMPLEX DISASSEMBLY 14 217 0.00182 0.00593
1430 FACE DEVELOPMENT 6 50 0.001879 0.006115
1431 METANEPHRIC NEPHRON MORPHOGENESIS 4 21 0.001956 0.006319
1432 NECROPTOTIC PROCESS 4 21 0.001956 0.006319
1433 REGULATION OF PROTEIN IMPORT INTO NUCLEUS TRANSLOCATION 4 21 0.001956 0.006319
1434 CHONDROCYTE DEVELOPMENT 4 21 0.001956 0.006319
1435 DECIDUALIZATION 4 21 0.001956 0.006319
1436 POSITIVE T CELL SELECTION 4 21 0.001956 0.006319
1437 VIRAL GENOME REPLICATION 4 21 0.001956 0.006319
1438 REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS 4 21 0.001956 0.006319
1439 NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 4 21 0.001956 0.006319
1440 NEGATIVE REGULATION OF PROTEIN ACETYLATION 4 21 0.001956 0.006319
1441 ORGAN GROWTH 7 68 0.001985 0.006406
1442 NERVE DEVELOPMENT 7 68 0.001985 0.006406
1443 REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS 8 87 0.002009 0.006477
1444 NADH METABOLIC PROCESS 5 35 0.002053 0.006603
1445 MEMBRANE PROTEIN PROTEOLYSIS 5 35 0.002053 0.006603
1446 RESPONSE TO MONOAMINE 5 35 0.002053 0.006603
1447 REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES 5 35 0.002053 0.006603
1448 REGULATION OF CELLULAR KETONE METABOLIC PROCESS 12 173 0.002073 0.006662
1449 NEURAL CREST CELL MIGRATION 6 51 0.002083 0.006686
1450 REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 6 51 0.002083 0.006686
1451 NUCLEAR IMPORT 10 129 0.00213 0.00682
1452 CELL JUNCTION ASSEMBLY 10 129 0.00213 0.00682
1453 REGULATION OF CAMP METABOLIC PROCESS 10 129 0.00213 0.00682
1454 NEGATIVE REGULATION OF MULTI ORGANISM PROCESS 11 151 0.002139 0.006846
1455 REGULATION OF HEART CONTRACTION 14 221 0.002156 0.006893
1456 MICROTUBULE CYTOSKELETON ORGANIZATION 19 348 0.002204 0.007042
1457 POSITIVE REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS 9 109 0.002281 0.007283
1458 POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 6 52 0.002304 0.007353
1459 NEGATIVE REGULATION OF MUSCLE CONTRACTION 4 22 0.002341 0.007406
1460 BONE CELL DEVELOPMENT 4 22 0.002341 0.007406
1461 SEX DETERMINATION 4 22 0.002341 0.007406
1462 POSITIVE REGULATION OF PROTEIN OLIGOMERIZATION 4 22 0.002341 0.007406
1463 CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 5 36 0.002334 0.007406
1464 REGULATION OF CELLULAR EXTRAVASATION 4 22 0.002341 0.007406
1465 POSITIVE REGULATION OF AXON EXTENSION 5 36 0.002334 0.007406
1466 REGULATION OF T CELL CYTOKINE PRODUCTION 4 22 0.002341 0.007406
1467 TOXIN TRANSPORT 5 36 0.002334 0.007406
1468 NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT 5 36 0.002334 0.007406
1469 POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY 5 36 0.002334 0.007406
1470 EMBRYONIC PLACENTA MORPHOGENESIS 4 22 0.002341 0.007406
1471 HISTONE H3 DEACETYLATION 4 22 0.002341 0.007406
1472 MUSCLE ORGAN MORPHOGENESIS 7 70 0.002348 0.007421
1473 MALE GAMETE GENERATION 24 486 0.002386 0.007533
1474 RETINA DEVELOPMENT IN CAMERA TYPE EYE 10 131 0.002385 0.007533
1475 REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS 16 274 0.002472 0.007798
1476 URETER DEVELOPMENT 3 11 0.002522 0.007828
1477 REGULATION OF CHOLESTEROL HOMEOSTASIS 3 11 0.002522 0.007828
1478 NEGATIVE REGULATION OF SODIUM ION TRANSPORT 3 11 0.002522 0.007828
1479 NEGATIVE REGULATION OF GLYCOLYTIC PROCESS 3 11 0.002522 0.007828
1480 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE 3 11 0.002522 0.007828
1481 VENTRAL SPINAL CORD INTERNEURON SPECIFICATION 3 11 0.002522 0.007828
1482 RESPONSE TO GRAVITY 3 11 0.002522 0.007828
1483 REGULATION OF T HELPER 2 CELL DIFFERENTIATION 3 11 0.002522 0.007828
1484 POSITIVE REGULATION OF CELL DIVISION 10 132 0.002522 0.007828
1485 REGULATION OF CHRONIC INFLAMMATORY RESPONSE 3 11 0.002522 0.007828
1486 MUSCLE ATROPHY 3 11 0.002522 0.007828
1487 SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT 3 11 0.002522 0.007828
1488 REGULATION OF PHOSPHOLIPASE A2 ACTIVITY 3 11 0.002522 0.007828
1489 BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS 3 11 0.002522 0.007828
1490 CYCLOOXYGENASE PATHWAY 3 11 0.002522 0.007828
1491 NEGATIVE REGULATION OF CELLULAR SENESCENCE 3 11 0.002522 0.007828
1492 NEGATIVE REGULATION OF COENZYME METABOLIC PROCESS 3 11 0.002522 0.007828
1493 POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION 3 11 0.002522 0.007828
1494 NEGATIVE REGULATION OF COFACTOR METABOLIC PROCESS 3 11 0.002522 0.007828
1495 REGULATION OF INTERFERON GAMMA SECRETION 3 11 0.002522 0.007828
1496 CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION 3 11 0.002522 0.007828
1497 VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS 3 11 0.002522 0.007828
1498 NEGATIVE REGULATION OF NECROTIC CELL DEATH 3 11 0.002522 0.007828
1499 RESPONSE TO STARVATION 11 154 0.002496 0.007828
1500 POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 6 53 0.002542 0.007879
1501 NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS 6 53 0.002542 0.007879
1502 CELL FATE SPECIFICATION 7 71 0.002547 0.00789
1503 POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS 9 111 0.002582 0.007988
1504 NEGATIVE REGULATION OF DNA METABOLIC PROCESS 9 111 0.002582 0.007988
1505 SENSORY PERCEPTION OF MECHANICAL STIMULUS 11 155 0.002625 0.00811
1506 REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS 11 155 0.002625 0.00811
1507 CELLULAR RESPONSE TO LIGHT STIMULUS 8 91 0.002668 0.008239
1508 ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT 4 23 0.002776 0.008515
1509 POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION 4 23 0.002776 0.008515
1510 CRANIAL NERVE MORPHOGENESIS 4 23 0.002776 0.008515
1511 REGULATION OF OSTEOBLAST PROLIFERATION 4 23 0.002776 0.008515
1512 EPIBOLY 4 23 0.002776 0.008515
1513 ACTIN FILAMENT POLYMERIZATION 4 23 0.002776 0.008515
1514 TRABECULA FORMATION 4 23 0.002776 0.008515
1515 STRIATED MUSCLE ADAPTATION 4 23 0.002776 0.008515
1516 POSITIVE REGULATION OF STEROID METABOLIC PROCESS 4 23 0.002776 0.008515
1517 REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER 4 23 0.002776 0.008515
1518 POSTREPLICATION REPAIR 6 54 0.002797 0.008563
1519 MONOSACCHARIDE TRANSPORT 6 54 0.002797 0.008563
1520 REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL 6 54 0.002797 0.008563
1521 HEXOSE METABOLIC PROCESS 11 157 0.002899 0.008869
1522 PROTEIN CATABOLIC PROCESS 27 579 0.002938 0.008982
1523 SINGLE ORGANISM BIOSYNTHETIC PROCESS 52 1340 0.00295 0.009012
1524 REGULATION OF DOUBLE STRAND BREAK REPAIR 5 38 0.002977 0.009054
1525 SPINDLE LOCALIZATION 5 38 0.002977 0.009054
1526 POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING 5 38 0.002977 0.009054
1527 REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION 5 38 0.002977 0.009054
1528 CYTOKINE SECRETION 5 38 0.002977 0.009054
1529 CELL GROWTH 10 135 0.00297 0.009054
1530 REGULATION OF LYMPHOCYTE MIGRATION 5 38 0.002977 0.009054
1531 EMBRYONIC HEART TUBE DEVELOPMENT 7 73 0.002984 0.009063
1532 G1 DNA DAMAGE CHECKPOINT 7 73 0.002984 0.009063
1533 REGULATION OF ENDOTHELIAL CELL MIGRATION 9 114 0.003093 0.009387
1534 TOLERANCE INDUCTION 3 12 0.003297 0.009842
1535 CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS 4 24 0.003263 0.009842
1536 REGULATION OF TIMING OF CELL DIFFERENTIATION 3 12 0.003297 0.009842
1537 POSITIVE REGULATION OF THYMOCYTE AGGREGATION 3 12 0.003297 0.009842
1538 NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS 3 12 0.003297 0.009842
1539 CELLULAR RESPONSE TO ATP 3 12 0.003297 0.009842
1540 NEGATIVE REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS 3 12 0.003297 0.009842
1541 EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS 4 24 0.003263 0.009842
1542 REGULATION OF CHEMOKINE SECRETION 3 12 0.003297 0.009842
1543 RESPONSE TO STEROL 4 24 0.003263 0.009842
1544 POST EMBRYONIC MORPHOGENESIS 3 12 0.003297 0.009842
1545 SPINAL CORD PATTERNING 4 24 0.003263 0.009842
1546 REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS 3 12 0.003297 0.009842
1547 PERK MEDIATED UNFOLDED PROTEIN RESPONSE 3 12 0.003297 0.009842
1548 I KAPPAB PHOSPHORYLATION 3 12 0.003297 0.009842
1549 REGULATION OF DNA BIOSYNTHETIC PROCESS 8 94 0.003266 0.009842
1550 REGULATION OF DEVELOPMENT HETEROCHRONIC 3 12 0.003297 0.009842
1551 POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS 3 12 0.003297 0.009842
1552 CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 4 24 0.003263 0.009842
1553 CELL ADHESION MEDIATED BY INTEGRIN 3 12 0.003297 0.009842
1554 RENAL ABSORPTION 3 12 0.003297 0.009842
1555 ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION 4 24 0.003263 0.009842
1556 ORGANELLE LOCALIZATION 21 415 0.003283 0.009842
1557 ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 3 12 0.003297 0.009842
1558 REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY 3 12 0.003297 0.009842
1559 REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION 3 12 0.003297 0.009842
1560 ATP GENERATION FROM ADP 5 39 0.003343 0.009951
1561 ERBB2 SIGNALING PATHWAY 5 39 0.003343 0.009951
1562 EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 5 39 0.003343 0.009951
1563 COCHLEA DEVELOPMENT 5 39 0.003343 0.009951
1564 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 14 232 0.003351 0.00997
NumGOOverlapSizeP ValueAdj. P Value
1 RECEPTOR BINDING 130 1476 3.684e-36 3.423e-33
2 MACROMOLECULAR COMPLEX BINDING 116 1399 1.296e-29 6.021e-27
3 ENZYME BINDING 130 1737 5.294e-29 1.639e-26
4 IDENTICAL PROTEIN BINDING 103 1209 4.27e-27 9.918e-25
5 TRANSCRIPTION FACTOR BINDING 63 524 2.429e-24 4.513e-22
6 REGULATORY REGION NUCLEIC ACID BINDING 74 818 6.322e-21 9.789e-19
7 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 64 629 8.553e-21 1.135e-18
8 DOUBLE STRANDED DNA BINDING 65 764 4.29e-17 4.982e-15
9 PROTEIN KINASE ACTIVITY 58 640 1.44e-16 1.487e-14
10 PROTEIN DIMERIZATION ACTIVITY 81 1149 2.652e-16 2.464e-14
11 SEQUENCE SPECIFIC DNA BINDING 76 1037 3.109e-16 2.626e-14
12 KINASE ACTIVITY 67 842 3.961e-16 3.067e-14
13 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 39 315 7.449e-16 5.323e-14
14 KINASE BINDING 55 606 8.77e-16 5.819e-14
15 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 54 588 9.904e-16 6.134e-14
16 CYTOKINE RECEPTOR BINDING 36 271 1.078e-15 6.259e-14
17 PROTEIN COMPLEX BINDING 69 935 6.127e-15 3.348e-13
18 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 80 1199 8.863e-15 4.574e-13
19 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 71 992 1.11e-14 5.427e-13
20 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 38 328 1.558e-14 7.237e-13
21 CHROMATIN BINDING 44 435 1.741e-14 7.703e-13
22 PROTEIN HOMODIMERIZATION ACTIVITY 57 722 1.073e-13 4.529e-12
23 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC BINDING 20 90 1.511e-13 6.101e-12
24 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 30 226 2.813e-13 1.089e-11
25 CORE PROMOTER BINDING 24 152 1.582e-12 5.88e-11
26 CYTOKINE ACTIVITY 28 219 4.473e-12 1.598e-10
27 GROWTH FACTOR RECEPTOR BINDING 20 129 1.627e-10 5.599e-09
28 PROTEIN HETERODIMERIZATION ACTIVITY 38 468 7.619e-10 2.528e-08
29 GLYCOPROTEIN BINDING 17 101 1.046e-09 3.351e-08
30 PROTEIN TYROSINE KINASE ACTIVITY 22 176 1.389e-09 4.301e-08
31 HISTONE DEACETYLASE BINDING 17 105 1.946e-09 5.651e-08
32 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 19 133 1.941e-09 5.651e-08
33 SIGNAL TRANSDUCER ACTIVITY 87 1731 2.284e-09 6.429e-08
34 PROTEIN SERINE THREONINE KINASE ACTIVITY 36 445 2.383e-09 6.512e-08
35 MOLECULAR FUNCTION REGULATOR 73 1353 2.91e-09 7.724e-08
36 GROWTH FACTOR BINDING 18 123 3.491e-09 9.007e-08
37 CELL ADHESION MOLECULE BINDING 22 186 3.967e-09 9.96e-08
38 GLYCOSAMINOGLYCAN BINDING 23 205 4.92e-09 1.203e-07
39 GROWTH FACTOR ACTIVITY 20 160 7.797e-09 1.857e-07
40 CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING 16 101 8.066e-09 1.873e-07
41 PROTEIN DOMAIN SPECIFIC BINDING 42 624 2.512e-08 5.692e-07
42 PEPTIDASE REGULATOR ACTIVITY 22 214 5.236e-08 1.158e-06
43 RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 15 104 8.627e-08 1.864e-06
44 RECEPTOR ACTIVITY 79 1649 1.092e-07 2.306e-06
45 CYTOKINE BINDING 14 92 1.17e-07 2.415e-06
46 VIRUS RECEPTOR ACTIVITY 12 70 2.466e-07 4.843e-06
47 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 12 70 2.466e-07 4.843e-06
48 ENZYME REGULATOR ACTIVITY 53 959 2.502e-07 4.843e-06
49 ADENYL NUCLEOTIDE BINDING 73 1514 2.795e-07 5.299e-06
50 SMAD BINDING 12 72 3.395e-07 6.309e-06
51 PEPTIDASE ACTIVATOR ACTIVITY 9 38 4.499e-07 8.195e-06
52 PROTEASE BINDING 14 104 5.539e-07 9.896e-06
53 CORE PROMOTER PROXIMAL REGION DNA BINDING 28 371 6.07e-07 1.064e-05
54 INTEGRIN BINDING 14 105 6.24e-07 1.074e-05
55 RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY 13 92 7.977e-07 1.347e-05
56 RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING 10 53 9.915e-07 1.645e-05
57 TRANSCRIPTION COACTIVATOR ACTIVITY 24 296 1.101e-06 1.795e-05
58 LOW DENSITY LIPOPROTEIN PARTICLE BINDING 6 15 1.287e-06 2.061e-05
59 G PROTEIN COUPLED RECEPTOR BINDING 22 259 1.429e-06 2.25e-05
60 HORMONE RECEPTOR BINDING 17 168 2.137e-06 3.31e-05
61 TRANSITION METAL ION BINDING 66 1400 2.415e-06 3.678e-05
62 RECEPTOR SIGNALING PROTEIN ACTIVITY 17 172 2.955e-06 4.428e-05
63 HEPARIN BINDING 16 157 3.87e-06 5.706e-05
64 PLATELET DERIVED GROWTH FACTOR BINDING 5 11 4.911e-06 7.128e-05
65 PHOSPHATASE BINDING 16 162 5.812e-06 8.306e-05
66 HISTONE ACETYLTRANSFERASE BINDING 7 28 5.976e-06 8.412e-05
67 TRANSCRIPTION COREPRESSOR ACTIVITY 19 221 6.223e-06 8.628e-05
68 RIBONUCLEOTIDE BINDING 80 1860 6.368e-06 8.699e-05
69 SERINE HYDROLASE ACTIVITY 20 242 6.469e-06 8.71e-05
70 CALCIUM ION BINDING 39 697 7.777e-06 0.0001032
71 SIGNALING RECEPTOR ACTIVITY 64 1393 8.002e-06 0.0001047
72 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 11 81 8.317e-06 0.0001073
73 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 16 168 9.263e-06 0.0001179
74 SULFUR COMPOUND BINDING 19 234 1.41e-05 0.000177
75 PROTEIN PHOSPHATASE BINDING 13 120 1.607e-05 0.0001905
76 LIPOPROTEIN PARTICLE RECEPTOR BINDING 6 22 1.64e-05 0.0001905
77 FERROUS IRON BINDING 6 22 1.64e-05 0.0001905
78 CHEMOKINE RECEPTOR BINDING 9 57 1.596e-05 0.0001905
79 ACTIVATING TRANSCRIPTION FACTOR BINDING 9 57 1.596e-05 0.0001905
80 REPRESSING TRANSCRIPTION FACTOR BINDING 9 57 1.596e-05 0.0001905
81 HEAT SHOCK PROTEIN BINDING 11 89 2.075e-05 0.0002351
82 CYTOKINE RECEPTOR ACTIVITY 11 89 2.075e-05 0.0002351
83 PROTEIN LIPID COMPLEX BINDING 6 24 2.83e-05 0.0003168
84 ICOSANOID RECEPTOR ACTIVITY 5 15 2.926e-05 0.0003236
85 CHEMOKINE ACTIVITY 8 48 3.158e-05 0.0003451
86 KINASE REGULATOR ACTIVITY 16 186 3.299e-05 0.0003564
87 RETINOID X RECEPTOR BINDING 5 17 5.773e-05 0.0006164
88 BHLH TRANSCRIPTION FACTOR BINDING 6 28 7.247e-05 0.000765
89 CYSTEINE TYPE ENDOPEPTIDASE REGULATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS 7 42 9.914e-05 0.001035
90 PHOSPHATIDYLINOSITOL 3 KINASE BINDING 6 30 0.0001092 0.001128
91 PROTEIN C TERMINUS BINDING 15 186 0.0001199 0.001224
92 ENDOPEPTIDASE ACTIVITY 26 448 0.0001441 0.001455
93 RECEPTOR REGULATOR ACTIVITY 7 45 0.0001558 0.001557
94 RECEPTOR ACTIVATOR ACTIVITY 6 32 0.0001595 0.001576
95 ENHANCER BINDING 10 93 0.0001612 0.001577
96 ENZYME INHIBITOR ACTIVITY 23 378 0.0001744 0.001688
97 PEPTIDOGLYCAN BINDING 4 12 0.000195 0.001868
98 KINASE ACTIVATOR ACTIVITY 8 62 0.0002053 0.001937
99 TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY BINDING 7 47 0.0002064 0.001937
100 CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 6 34 0.0002264 0.002104
101 SH3 DOMAIN BINDING 11 116 0.000237 0.00218
102 PEPTIDASE INHIBITOR ACTIVITY 14 177 0.000245 0.002232
103 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 8 64 0.0002567 0.002316
104 STEROID HORMONE RECEPTOR BINDING 9 81 0.0002655 0.002372
105 CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS 5 23 0.0002756 0.002418
106 LOW DENSITY LIPOPROTEIN RECEPTOR ACTIVITY 4 13 0.0002759 0.002418
107 COLLAGEN BINDING 8 65 0.0002862 0.002462
108 RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC DNA BINDING 8 65 0.0002862 0.002462
109 STRUCTURAL CONSTITUENT OF CYTOSKELETON 10 100 0.0002935 0.002501
110 AMIDE BINDING 18 272 0.00032 0.002702
111 EPHRIN RECEPTOR BINDING 5 24 0.0003407 0.002852
112 LONG CHAIN FATTY ACID BINDING 4 14 0.0003783 0.003138
113 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 10 105 0.0004355 0.00358
114 PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY 6 39 0.0004917 0.004007
115 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC BINDING 5 26 0.000505 0.00408
116 ESTROGEN RECEPTOR BINDING 6 40 0.0005659 0.004532
117 RNA POLYMERASE II TRANSCRIPTION COFACTOR ACTIVITY 9 91 0.0006336 0.005031
118 TRANSFORMING GROWTH FACTOR BETA BINDING 4 16 0.0006598 0.005065
119 RECEPTOR AGONIST ACTIVITY 4 16 0.0006598 0.005065
120 LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY 4 16 0.0006598 0.005065
121 CXCR CHEMOKINE RECEPTOR BINDING 4 16 0.0006598 0.005065
122 ENZYME ACTIVATOR ACTIVITY 25 471 0.0007206 0.005487
123 METALLOENDOPEPTIDASE ACTIVITY 10 113 0.0007785 0.00588
124 EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT 8 76 0.000832 0.006181
125 LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR BINDING 4 17 0.000845 0.006181
126 NAD DEPENDENT PROTEIN DEACETYLASE ACTIVITY 4 17 0.000845 0.006181
127 SIGNALING PATTERN RECOGNITION RECEPTOR ACTIVITY 4 17 0.000845 0.006181
128 HSP70 PROTEIN BINDING 5 30 0.001004 0.007172
129 MHC PROTEIN BINDING 5 30 0.001004 0.007172
130 TUMOR NECROSIS FACTOR RECEPTOR BINDING 5 30 0.001004 0.007172
131 RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 15 228 0.001044 0.007404
132 RETINOIC ACID RECEPTOR BINDING 6 45 0.001075 0.007568
133 ZINC ION BINDING 48 1155 0.001089 0.007608
134 FATTY ACID BINDING 5 31 0.001171 0.00812
135 NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY 6 46 0.00121 0.008324
136 LIPID BINDING 31 657 0.001239 0.008464
137 CYCLIN BINDING 4 19 0.00132 0.00876
138 NITRIC OXIDE SYNTHASE BINDING 4 19 0.00132 0.00876
139 PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY 4 19 0.00132 0.00876
140 HISTONE KINASE ACTIVITY 4 19 0.00132 0.00876
141 METALLOPEPTIDASE ACTIVITY 13 188 0.001414 0.009318
142 PEPTIDASE ACTIVITY 31 663 0.001429 0.009351
143 TRANSCRIPTION FACTOR ACTIVITY DIRECT LIGAND REGULATED SEQUENCE SPECIFIC DNA BINDING 6 48 0.001516 0.009837
144 MONOCARBOXYLIC ACID BINDING 7 65 0.001525 0.009837
145 PROTEIN N TERMINUS BINDING 9 103 0.00154 0.009868
NumGOOverlapSizeP ValueAdj. P Value
1 CELL SURFACE 83 757 3.755e-29 2.193e-26
2 EXTRACELLULAR SPACE 108 1376 1.685e-25 4.919e-23
3 MEMBRANE MICRODOMAIN 42 288 1.186e-19 1.731e-17
4 SIDE OF MEMBRANE 51 428 1.128e-19 1.731e-17
5 EXTRACELLULAR MATRIX 47 426 7.218e-17 8.431e-15
6 EXTERNAL SIDE OF PLASMA MEMBRANE 35 238 1.101e-16 1.072e-14
7 INTRINSIC COMPONENT OF PLASMA MEMBRANE 102 1649 1.516e-16 1.265e-14
8 MEMBRANE REGION 75 1134 1.081e-13 7.893e-12
9 RECEPTOR COMPLEX 36 327 3.697e-13 2.399e-11
10 ANCHORING JUNCTION 43 489 4.144e-12 2.42e-10
11 CELL SUBSTRATE JUNCTION 38 398 6.671e-12 3.542e-10
12 PROTEINACEOUS EXTRACELLULAR MATRIX 35 356 2.045e-11 9.954e-10
13 PLASMA MEMBRANE RECEPTOR COMPLEX 24 175 3.466e-11 1.557e-09
14 PERINUCLEAR REGION OF CYTOPLASM 46 642 7.287e-10 3.04e-08
15 TRANSCRIPTION FACTOR COMPLEX 29 298 1.417e-09 5.518e-08
16 NUCLEAR CHROMOSOME 40 523 1.546e-09 5.642e-08
17 CHROMOSOME 55 880 2.22e-09 7.625e-08
18 INTRACELLULAR VESICLE 69 1259 4.443e-09 1.441e-07
19 VESICLE LUMEN 16 106 1.649e-08 5.067e-07
20 CELL LEADING EDGE 29 350 5.259e-08 1.536e-06
21 CELL JUNCTION 62 1151 5.529e-08 1.537e-06
22 ENDOCYTIC VESICLE 24 256 7.65e-08 1.942e-06
23 CYTOPLASMIC VESICLE PART 40 601 7.399e-08 1.942e-06
24 MEDIATOR COMPLEX 9 34 1.589e-07 3.867e-06
25 CHROMATIN 32 441 2.315e-07 5.408e-06
26 PLASMA MEMBRANE RAFT 13 86 3.588e-07 8.059e-06
27 PLASMA MEMBRANE REGION 51 929 5.231e-07 1.131e-05
28 VACUOLE 60 1180 6.538e-07 1.364e-05
29 PLASMA MEMBRANE PROTEIN COMPLEX 34 510 6.954e-07 1.4e-05
30 PROTEIN COMPLEX INVOLVED IN CELL ADHESION 8 30 7.412e-07 1.443e-05
31 ENDOSOME 45 793 1.046e-06 1.97e-05
32 ENDOPLASMIC RETICULUM LUMEN 19 201 1.533e-06 2.798e-05
33 CYTOPLASMIC SIDE OF MEMBRANE 17 170 2.516e-06 4.453e-05
34 NUCLEAR CHROMATIN 23 291 2.838e-06 4.875e-05
35 TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS 20 237 4.725e-06 7.881e-05
36 CELL PROJECTION 78 1786 4.858e-06 7.881e-05
37 EXTRACELLULAR MATRIX COMPONENT 14 125 5.165e-06 8.152e-05
38 NUCLEAR TRANSCRIPTION FACTOR COMPLEX 14 127 6.226e-06 9.568e-05
39 BANDED COLLAGEN FIBRIL 5 12 8.237e-06 0.0001233
40 ENDOCYTIC VESICLE MEMBRANE 15 152 1.144e-05 0.000167
41 EXTRINSIC COMPONENT OF MEMBRANE 20 252 1.18e-05 0.0001681
42 LAMELLIPODIUM 16 172 1.248e-05 0.0001735
43 RNA POLYMERASE II TRANSCRIPTION FACTOR COMPLEX 12 101 1.324e-05 0.0001798
44 COLLAGEN TRIMER 11 88 1.862e-05 0.0002471
45 PLATELET ALPHA GRANULE 10 75 2.517e-05 0.0003267
46 APICAL PART OF CELL 24 361 3.181e-05 0.0003982
47 ACTOMYOSIN 9 62 3.204e-05 0.0003982
48 VESICLE MEMBRANE 30 512 3.798e-05 0.000462
49 GOLGI APPARATUS 63 1445 4.635e-05 0.0005524
50 CELL BODY 29 494 4.934e-05 0.0005763
51 ENDOPLASMIC RETICULUM 69 1631 5.035e-05 0.0005765
52 NUCLEOPLASM PART 37 708 5.731e-05 0.0006437
53 SECRETORY GRANULE 23 352 6.033e-05 0.0006564
54 EXTRINSIC COMPONENT OF PLASMA MEMBRANE 13 136 6.07e-05 0.0006564
55 SECRETORY GRANULE LUMEN 10 85 7.524e-05 0.0007912
56 NEUROMUSCULAR JUNCTION 8 54 7.587e-05 0.0007912
57 PHAGOCYTIC CUP 5 18 7.821e-05 0.0008013
58 PLATELET ALPHA GRANULE LUMEN 8 55 8.677e-05 0.0008737
59 ACTIN FILAMENT BUNDLE 8 57 0.0001125 0.001095
60 SOMATODENDRITIC COMPARTMENT 34 650 0.0001123 0.001095
61 SPINDLE MICROTUBULE 8 58 0.0001275 0.001221
62 EARLY ENDOSOME 20 301 0.0001438 0.001354
63 OUTER MEMBRANE 15 190 0.0001519 0.001408
64 NEURON PROJECTION 44 942 0.000157 0.001432
65 MEMBRANE PROTEIN COMPLEX 46 1020 0.0002461 0.002177
66 RUFFLE 13 156 0.0002432 0.002177
67 DNA POLYMERASE COMPLEX 4 13 0.0002759 0.002335
68 COMPLEX OF COLLAGEN TRIMERS 5 23 0.0002756 0.002335
69 APICAL PLASMA MEMBRANE 19 292 0.0002728 0.002335
70 NEURON PART 54 1265 0.0002813 0.002347
71 CHROMOSOMAL REGION 20 330 0.000477 0.003869
72 TRANSFERASE COMPLEX 34 703 0.000475 0.003869
73 ADA2 GCN5 ADA3 TRANSCRIPTION ACTIVATOR COMPLEX 4 15 0.0005052 0.004042
74 ER TO GOLGI TRANSPORT VESICLE 8 71 0.000526 0.00412
75 SECRETORY VESICLE 25 461 0.0005291 0.00412
76 PROTEIN KINASE COMPLEX 9 90 0.0005842 0.004489
77 CATALYTIC COMPLEX 45 1038 0.0006634 0.005031
78 TRANSCRIPTIONAL REPRESSOR COMPLEX 8 74 0.000696 0.005211
79 ACTIN CYTOSKELETON 24 444 0.0007107 0.005234
80 AXON 23 418 0.000717 0.005234
81 BASEMENT MEMBRANE 9 93 0.0007426 0.005302
82 LYTIC VACUOLE 27 526 0.0007445 0.005302
83 VACUOLAR LUMEN 10 115 0.0008923 0.006279
84 CYTOSKELETON 74 1967 0.0009295 0.006462
85 ENDOPLASMIC RETICULUM PART 48 1163 0.001257 0.008635
86 COATED VESICLE 15 234 0.001354 0.009192

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 TNF_signaling_pathway_hsa04668 31 108 6.596e-24 3.43e-22
2 PI3K_Akt_signaling_pathway_hsa04151 51 352 1.596e-23 4.151e-22
3 Cytokine_cytokine_receptor_interaction_hsa04060 41 270 7.153e-20 1.24e-18
4 FoxO_signaling_pathway_hsa04068 28 132 7.18e-18 9.334e-17
5 Apoptosis_hsa04210 28 138 2.489e-17 2.589e-16
6 MAPK_signaling_pathway_hsa04010 39 295 7.858e-17 6.81e-16
7 Focal_adhesion_hsa04510 30 199 8.94e-15 6.641e-14
8 Cellular_senescence_hsa04218 25 160 6.888e-13 4.477e-12
9 Cell_cycle_hsa04110 22 124 1.203e-12 6.948e-12
10 Rap1_signaling_pathway_hsa04015 26 206 3.525e-11 1.833e-10
11 Jak_STAT_signaling_pathway_hsa04630 23 162 4.358e-11 2.06e-10
12 Hippo_signaling_pathway_hsa04390 22 154 1.023e-10 4.432e-10
13 Phagosome_hsa04145 21 152 5.137e-10 2.055e-09
14 NF_kappa_B_signaling_pathway_hsa04064 16 95 3.217e-09 1.195e-08
15 Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 19 139 4.126e-09 1.43e-08
16 Regulation_of_actin_cytoskeleton_hsa04810 22 208 3.134e-08 1.018e-07
17 TGF_beta_signaling_pathway_hsa04350 14 84 3.57e-08 1.092e-07
18 HIF_1_signaling_pathway_hsa04066 15 100 5.043e-08 1.403e-07
19 Ras_signaling_pathway_hsa04014 23 232 5.128e-08 1.403e-07
20 Adherens_junction_hsa04520 12 72 3.395e-07 8.828e-07
21 p53_signaling_pathway_hsa04115 11 68 1.429e-06 3.413e-06
22 ECM_receptor_interaction_hsa04512 12 82 1.444e-06 3.413e-06
23 Necroptosis_hsa04217 17 164 1.53e-06 3.459e-06
24 mTOR_signaling_pathway_hsa04150 14 151 4.477e-05 9.701e-05
25 Sphingolipid_signaling_pathway_hsa04071 12 118 6.341e-05 0.000131
26 Apelin_signaling_pathway_hsa04371 13 137 6.549e-05 0.000131
27 cAMP_signaling_pathway_hsa04024 16 198 7.015e-05 0.0001351
28 AMPK_signaling_pathway_hsa04152 12 121 8.104e-05 0.0001505
29 Calcium_signaling_pathway_hsa04020 15 182 9.397e-05 0.0001685
30 Gap_junction_hsa04540 10 88 0.0001012 0.0001754
31 Autophagy_animal_hsa04140 12 128 0.0001393 0.0002336
32 Apoptosis_multiple_species_hsa04215 6 33 0.0001907 0.0003098
33 ErbB_signaling_pathway_hsa04012 9 85 0.0003822 0.0006022
34 Oocyte_meiosis_hsa04114 11 124 0.0004228 0.0006466
35 VEGF_signaling_pathway_hsa04370 7 59 0.0008548 0.00127
36 cGMP_PKG_signaling_pathway_hsa04022 12 163 0.001251 0.001807
37 Cell_adhesion_molecules_.CAMs._hsa04514 11 145 0.00155 0.002178
38 Wnt_signaling_pathway_hsa04310 11 146 0.001638 0.002241
39 Phospholipase_D_signaling_pathway_hsa04072 10 146 0.005182 0.006909
40 Notch_signaling_pathway_hsa04330 5 48 0.008205 0.01067
41 Mitophagy_animal_hsa04137 5 65 0.02764 0.03442
42 Endocytosis_hsa04144 12 244 0.0278 0.03442
43 Neuroactive_ligand_receptor_interaction_hsa04080 13 278 0.03226 0.03901
44 Tight_junction_hsa04530 9 170 0.03542 0.04186
45 Hippo_signaling_pathway_multiple_species_hsa04392 3 29 0.03946 0.0456
46 Ferroptosis_hsa04216 3 40 0.08669 0.098
47 Hedgehog_signaling_pathway_hsa04340 3 47 0.1249 0.1382
48 Lysosome_hsa04142 5 123 0.2211 0.2395
49 Peroxisome_hsa04146 3 83 0.3712 0.3939

Quest ID: 57eca7dc6b4afd8f793f3fcb9b91aaae